<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_Wy6NTNQ">Effect of Mobile Phone Text Messaging Self-Management Support for Patients With Diabetes or Coronary Heart Disease in a Chronic Disease Management Program (SupportMe) on Blood Pressure: Pragmatic Randomized Controlled Trial</title>
				<funder>
					<orgName type="full">Western Sydney Local Health District</orgName>
					<orgName type="abbreviated">WSLHD</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100014467</idno>
				</funder>
				<funder>
					<orgName type="full">New South Wales Agency for Clinical Innovation, Diabetes NSW &amp; ACT (New South Wales &amp; Australian Capital Territory)</orgName>
				</funder>
				<funder>
					<orgName type="full">New South Wales Translational Research</orgName>
				</funder>
				<funder ref="#_HBANVAw">
					<orgName type="full">NHMRC</orgName>
				</funder>
				<funder>
					<orgName type="full">University of Sydney</orgName>
					<orgName type="abbreviated">USYD</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100001774</idno>
				</funder>
				<funder>
					<orgName type="full">Westmead Hospital Jerry Koutts Scholarship</orgName>
				</funder>
				<funder>
					<orgName type="full">George Institute.Diabetes NSW &amp; ACT</orgName>
				</funder>
				<funder ref="#_mmcDSmZ">
					<orgName type="full">National Heart Foundation</orgName>
				</funder>
				<funder ref="#_cun8Rrs">
					<orgName type="full">National Health and Medical Research Council</orgName>
					<orgName type="abbreviated">NHMRC</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100000925</idno>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Ngai</forename><forename type="middle">Wah</forename><surname>Cheung</surname></persName>
							<email>wah.cheung@sydney.edu.au</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Diabetes &amp; Endocrinology , Westmead Hospital , Westmead , Australia</note>
								<orgName type="department">Department of Diabetes &amp; Endocrinology</orgName>
								<orgName type="institution">Westmead Hospital</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Westmead Applied Research Centre , Faculty of Medicine &amp; Health , University of Sydney , Westmead , Australia</note>
								<orgName type="department" key="dep1">Westmead Applied Research Centre</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine &amp; Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Julie</forename><surname>Redfern</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> School of Health Sciences , Faculty of Medicine &amp; Health , University of Sydney , Sydney , Australia</note>
								<orgName type="department" key="dep1">School of Health Sciences</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine &amp; Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Aravinda</forename><surname>Thiagalingam</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Department of Cardiology , Westmead Hospital , Westmead , Australia</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Westmead Hospital</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD;</roleName><forename type="first">Tien-Ming</forename><surname>Hng</surname></persName>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>5</label> Blacktown Hospital , Blacktown , Australia</note>
								<orgName type="institution">Blacktown Hospital</orgName>
								<address>
									<settlement>Blacktown</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Simone</forename><surname>Marschner</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Westmead Applied Research Centre , Faculty of Medicine &amp; Health , University of Sydney , Westmead , Australia</note>
								<orgName type="department" key="dep1">Westmead Applied Research Centre</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine &amp; Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MSc</roleName><forename type="first">Rabbia</forename><surname>Haider</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Diabetes &amp; Endocrinology , Westmead Hospital , Westmead , Australia</note>
								<orgName type="department">Department of Diabetes &amp; Endocrinology</orgName>
								<orgName type="institution">Westmead Hospital</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MBBS, MPhil</roleName><forename type="first">Sonia</forename><surname>Faruquie</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Diabetes &amp; Endocrinology , Westmead Hospital , Westmead , Australia</note>
								<orgName type="department">Department of Diabetes &amp; Endocrinology</orgName>
								<orgName type="institution">Westmead Hospital</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Amy</forename><surname>Von Huben</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Westmead Applied Research Centre , Faculty of Medicine &amp; Health , University of Sydney , Westmead , Australia</note>
								<orgName type="department" key="dep1">Westmead Applied Research Centre</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine &amp; Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shelley</forename><surname>She</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Westmead Applied Research Centre , Faculty of Medicine &amp; Health , University of Sydney , Westmead , Australia</note>
								<orgName type="department" key="dep1">Westmead Applied Research Centre</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine &amp; Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Daniel</forename><surname>Mcintyre</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Westmead Applied Research Centre , Faculty of Medicine &amp; Health , University of Sydney , Westmead , Australia</note>
								<orgName type="department" key="dep1">Westmead Applied Research Centre</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine &amp; Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>BSc</roleName><forename type="first">Jin-Gun</forename><surname>Cho</surname></persName>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>6</label> Department of Respiratory Medicine , Westmead Hospital , Westmead , Australia</note>
								<orgName type="department">Department of Respiratory Medicine</orgName>
								<orgName type="institution">Westmead Hospital</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MBBS, MMed, PhD;</roleName><forename type="first">Clara</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Westmead Applied Research Centre , Faculty of Medicine &amp; Health , University of Sydney , Westmead , Australia</note>
								<orgName type="department" key="dep1">Westmead Applied Research Centre</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine &amp; Health</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Department of Cardiology , Westmead Hospital , Westmead , Australia</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Westmead Hospital</orgName>
								<address>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wah</forename><surname>Ngai</surname></persName>
						</author>
						<author>
							<persName><roleName>MBBS</roleName><surname>Cheung</surname></persName>
						</author>
						<author>
							<affiliation key="aff6">
								<note type="raw_affiliation">Department of Diabetes &amp; Endocrinology Westmead Hospital Hawkesbury Rd Westmead , 2145 Australia</note>
								<orgName type="department">Department of Diabetes &amp; Endocrinology</orgName>
								<address>
									<addrLine>Westmead Hospital Hawkesbury Rd</addrLine>
									<postCode>2145</postCode>
									<settlement>Westmead</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_x8DQTcX">Effect of Mobile Phone Text Messaging Self-Management Support for Patients With Diabetes or Coronary Heart Disease in a Chronic Disease Management Program (SupportMe) on Blood Pressure: Pragmatic Randomized Controlled Trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">E0985FFF6699A0973B4FEC2F15DED9EC</idno>
					<idno type="DOI">10.2196/38275</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T06:23+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_fgXpm65">diabetes mellitus</term>
					<term xml:id="_kqP3Rcs">type 2</term>
					<term xml:id="_pT54FfH">coronary disease</term>
					<term xml:id="_FwARkm5">chronic disease</term>
					<term xml:id="_cdgWebF">SMS text messaging</term>
					<term xml:id="_wPhZUzY">delivery of health care</term>
					<term xml:id="_E4VPDGe">integrated</term>
					<term xml:id="_RffNcne">self-management XSL •</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_R3m8Qxs"><p xml:id="_vm6dPvT"><s xml:id="_UGYfP8M">Background: Maintaining engagement and support for patients with chronic diseases is challenging.</s><s xml:id="_7Kxg7MS">SMS text messaging programs have complemented patient care in a variety of situations.</s><s xml:id="_RpqkC2J">However, such programs have not been widely translated into routine care.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_eN5Kmag">Objective:</head><p xml:id="_QZTukTE"><s xml:id="_MKrBP9p">We aimed to examine the implementation and utility of a customized SMS text message-based support program for patients with type 2 diabetes (T2D), coronary heart disease, or both within a chronic disease integrated care program.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_DV5PwYe">Methods:</head><p xml:id="_gR7bQeh"><s xml:id="_pXHncSR">We conducted a 6-month pragmatic parallel-group, single-blind randomized controlled trial that recruited people with T2D or coronary heart disease.</s><s xml:id="_JCbPps2">Intervention participants received 4 semipersonalized SMS text messages per week providing self-management support to supplement standard care.</s><s xml:id="_Ca6s7C3">Preprogrammed algorithms customized content based on participant characteristics, and the messages were sent at random times of the day and in random order by a fully automated SMS text messaging engine.</s><s xml:id="_WawmwsV">Control participants received standard care and only administrative SMS text messages.</s><s xml:id="_ZWprpPm">The primary outcome was systolic blood pressure.</s><s xml:id="_sCNCPE6">Evaluations were conducted face to face whenever possible by researchers blinded to randomization.</s><s xml:id="_gajEDpa">Participants with T2D were evaluated for glycated hemoglobin level.</s><s xml:id="_hEkZxHN">Participant-reported experience measures were evaluated using questionnaires and focus groups and summarized using proportions and thematic analysis.</s></p><p xml:id="_dkFuNaa"><s xml:id="_HwCsf5w">Results: A total of 902 participants were randomized (n=448, 49.7% to the intervention group and n=454, 50.3% to the control group).</s><s xml:id="_Ure6cE2">Primary outcome data were available for 89.5% (807/902) of the participants.</s><s xml:id="_4NxvKEe">At 6 months, there was no difference in systolic blood pressure between the intervention and control arms (adjusted mean difference=0.9</s><s xml:id="_f8VTRzf">mm Hg, 95% CI -1.1 to 2.1; P=.38).</s><s xml:id="_kA84qgN">Of 642 participants with T2D, there was no difference in glycated hemoglobin (adjusted mean difference=0.1%,</s><s xml:id="_K2SgXQR">95% CI -0.1% to 0.3%; P=.35).</s><s xml:id="_FpTv6Jn">Self-reported medication adherence was better in the intervention group (relative risk=0.82,</s><s xml:id="_SbBda54">95% CI</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="19" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="20" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="21" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="22" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="23" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6xcWErB">Introduction</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CTheA2n">Background</head><p xml:id="_M7RSvTt"><s xml:id="_zYdN6xj">In 2015, a total of 71% of the 56 million global deaths were due to chronic diseases <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_RJtmFmS">Coronary heart disease (CHD) and diabetes are 2 of the leading causes of chronic disease, together accounting for an estimated 41% of noncommunicable disease-related deaths of people aged &lt;70 years <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_T8cJdgp">Chronic diseases have long-lasting impacts on health and quality of life, as well as social and economic consequences <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>.</s><s xml:id="_DM4JeMz">It is common for people to have multiple chronic diseases.</s><s xml:id="_QSvPw9U">SMS text messaging is a simple digital intervention that has been shown to improve behavioral risk factors for chronic disease.</s><s xml:id="_DDMWdB6">It is an accessible and affordable means of delivering health messages.</s><s xml:id="_96dB5C5">Evidence for its use in smoking cessation has been well established through numerous randomized controlled trials (RCTs), and it is now a standard component of many smoking cessation programs <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b4">5]</ref>.</s><s xml:id="_u457CtF">Meta-analyses of clinical trials have shown the benefits of SMS text messaging for weight loss <ref type="bibr" target="#b5">[6]</ref>, physical activity <ref type="bibr" target="#b6">[7]</ref>, and medication adherence <ref type="bibr" target="#b7">[8]</ref>.</s></p><p xml:id="_VJS8p7v"><s xml:id="_TpCHKsY">There is also evidence that SMS text messaging can be an effective adjunct to clinical care in the management of chronic diseases, including CHD and type 2 diabetes (T2D).</s><s xml:id="_ypEE935">The Tobacco, Exercise, and Diet Messages (TEXT ME) study demonstrated that an SMS text messaging program providing motivation, support, and education to people with CHD improved multiple clinical risk factor measures, including low-density lipoprotein cholesterol (LDL-C) level, blood pressure (BP), BMI, physical activity, and smoking cessation <ref type="bibr" target="#b8">[9]</ref>.</s><s xml:id="_2KYGtvP">The program was cost-effective <ref type="bibr" target="#b9">[10]</ref>, engaging, useful, and easy to understand by patients <ref type="bibr" target="#b10">[11]</ref>.</s><s xml:id="_P8xxAyw">Furthermore, in a post hoc analysis, the TEXT ME program was shown to specifically improve cardiovascular risk factors in the diabetes subgroup <ref type="bibr" target="#b11">[12]</ref>.</s><s xml:id="_KVR3bXN">Among people with T2D, a meta-analysis of smaller SMS text messaging studies found that they achieved an overall reduction in glycated hemoglobin (HbA 1c ) level of 0.38% (4 mmol/mol) <ref type="bibr" target="#b12">[13]</ref>.</s><s xml:id="_bajnVXK">In total, 3 recent larger studies have similarly demonstrated modest improvements in HbA 1c level <ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref>.</s></p><p xml:id="_5zJmght"><s xml:id="_DmKUR6G">Apart from their use in smoking cessation, SMS text messaging programs have not been widely implemented or translated into routine health care for patients.</s><s xml:id="_y6ANaka">Moreover, as outlined earlier in this section, previous trials have generally focused on a single disease or condition.</s><s xml:id="_8EAnBf7">It may be impractical or overwhelming for patients to be enrolled in separate programs for each of their chronic conditions.</s><s xml:id="_YBEKk2w">We do not know how well SMS text messaging programs can be integrated into routine clinical care and whether they can be structured to support people with multiple chronic conditions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pvK4PVS">Objectives</head><p xml:id="_wmNYYN5"><s xml:id="_z4hA8eQ">Therefore, we sought to understand whether a healthy lifestyle self-management support SMS text messaging program can complement a health district-wide integrated care program in terms of its effect on clinical measures as well as patient engagement.</s><s xml:id="_mkK66zf">The primary goal of this implementation trial was to assess the effect of an SMS text messaging program for patients with 1 or 2 chronic health conditions, that is, T2D and CHD, in reducing BP.</s><s xml:id="_7MDw2Wz">Secondary goals were to <ref type="bibr" target="#b0">(1)</ref> develop an approach to integrating SMS text messaging program content suitable for patients with different or multiple chronic diseases;</s></p><p xml:id="_HE6Zzm4"><s xml:id="_nBznFPp">(2) examine the effect of the intervention on other clinical metrics; and (3) examine the feasibility, acceptability, barriers, and enablers of this program when implemented as part of a chronic disease integrated care program.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_f3wFrUB">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vCRC56F">Trial Design</head><p xml:id="_CRyx8Pf"><s xml:id="_utQDE28">SupportMe was a 6-month pragmatic parallel design, single-blind RCT comparing participants with T2D or CHD supported by a simple digital health intervention program with participants receiving usual care.</s></p><p xml:id="_uKhKyDe"><s xml:id="_ePrwCQQ">The study was conducted in the Western Sydney Local Health District (WSLHD) in the Australian state of New South Wales.</s><s xml:id="_kSuA2sC">The WSLHD serves a population of a million inhabitants.</s><s xml:id="_eRx3zQ8">In Western Sydney, 60% of the population is overweight or obese, and 5.9% is registered with diabetes compared with the national registered prevalence of 5.4% <ref type="bibr" target="#b16">[17]</ref>.</s></p><p xml:id="_tEyVy5d"><s xml:id="_uv7hgzU">In 2014 to 2015, the WSLHD implemented the Western Sydney Integrated Care Program (WSICP) <ref type="bibr" target="#b17">[18]</ref>.</s><s xml:id="_tsR3Jm5">The WSICP was a government initiative developed in the WSLHD to improve the continuity of and access to care for people with the chronic diseases of CHD, T2D, and chronic obstructive pulmonary disease across hospital settings and primary care.</s><s xml:id="_PhedM6c">It initially involved &gt;50 clinicians in 2 teaching hospitals and 200 general practitioners (GPs) <ref type="bibr" target="#b17">[18]</ref>.</s><s xml:id="_g539c3F">Components of the WSICP included standardization of care processes, the employment of nurse care coordinators to support patient care, rapid access to specialist support services for GPs, GP upskilling programs, and the use of IT for the sharing of data and care plans between hospital services and GPs <ref type="bibr" target="#b17">[18]</ref>.</s><s xml:id="_YPYZbBg">The model of routinely embedding digital enablers to support people living with chronic diseases into the WSICP arose from stakeholder meetings involving health administrators, hospital clinicians (medical and allied health), GPs, public health physicians, and consumers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_cGd4Kpq">Participants</head><p xml:id="_hDpkdFy"><s xml:id="_6VtP8tE">Recruitment for SupportMe was largely based on referrals from hospital specialist teams, community specialists and allied health staff, and GPs involved in the WSICP.</s><s xml:id="_QhqhbqY">Options for referral included a personal approach, fax, telephone, SMS text message, and email.</s><s xml:id="_5khUevp">Potential participants were given a detailed Participant Information and Consent Form to read, and every page of this needed to be acknowledged by being signed and witnessed.</s><s xml:id="_sbM8Fur">If enrolled, the referring clinician and GP were notified.</s><s xml:id="_HfYFvZt">Eligibility criteria were being aged ≥18 years, owning a mobile phone, being able to read SMS text messages in English, and having either CHD or suboptimally managed T2D.</s><s xml:id="_M3wsZTk">CHD was defined as previous myocardial infarction or documented &gt;50% occlusion of a major coronary artery on coronary angiography, and suboptimally managed T2D was defined as having an HbA 1c level in the last 6 months of 7.1% to 11.4% (54-101 mmol/mol).</s><s xml:id="_nh4bSy8">Exclusion criteria were the inability to complete the study procedures or follow-up or having a condition that rendered the participant unsuitable for the study (eg, severe disability or a considerable memory or behavioral disorder).</s><s xml:id="_XaaRcfK">Participants with type 1 diabetes were not excluded but could only be included based on CHD, not diabetes, as the diabetes SMS text messages were designed for T2D, not type 1 diabetes.</s><s xml:id="_KHJ4p7Y">Participants needed to be able to read and understand SMS text messages in English.</s><s xml:id="_GkREP3j">If needed, they were offered brief training at enrollment on how to read an SMS text message and delete or save messages.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KXGHfZb">Interventions</head><p xml:id="_FPwKfR2"><s xml:id="_syTGSgx">The protocol for SupportMe has been previously described <ref type="bibr" target="#b18">[19]</ref>.</s><s xml:id="_sSpWB35">Both intervention and control participants were encouraged to receive usual care from their regular health professionals.</s><s xml:id="_9r2pU4U">Control participants received a welcome message and a reminder for their 6-month follow-up appointment only.</s></p><p xml:id="_a3yQNHc"><s xml:id="_8SB6TNU">The intervention comprised 4 SMS text messages per week sent automatically at random times by an SMS text messaging engine between 9 AM and 5 PM on weekdays for 6 months.</s><s xml:id="_kKhbY2P">Messages were personalized (eg, including the participant's name and the hospital they were connected to), customized based on baseline clinical characteristics and risk factors (eg, smoking, insulin use, and vegetarianism) and chronic disease type (CHD, T2D, or both), and selected as per prespecified computerized algorithms <ref type="bibr" target="#b9">[10]</ref>.</s></p><p xml:id="_m47FDxT"><s xml:id="_CQXacn7">SMS text messages from a previous study <ref type="bibr" target="#b8">[9]</ref> were adopted, and new content was developed through our iterative co-design process with investigators, specialist physicians, allied health professionals, and consumers <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b20">21]</ref>.</s><s xml:id="_B3RC2xZ">The messages provided advice, motivation, information, or supportive tips on disease management.</s><s xml:id="_SgwRMNW">Each week, each of the four messages would address a different aspect: (1) general health, (2) nutrition, (3) physical activity, and (4) disease self-management.</s><s xml:id="_9bCCYTz">The distribution of messages is described in Table <ref type="table" target="#tab_0">S1</ref> in Multimedia Appendix 1.</s><s xml:id="_NqJAHaP">The messages within each category were sent to participants in random order.</s></p><p xml:id="_AnnHKSa"><s xml:id="_tmb6PPV">Each message was unique.</s><s xml:id="_YZ3KMGX">Examples of the SMS text messages include "Did you exercise today?" "Has your Dr checked &amp; discussed your cholesterol levels with you recently?</s><s xml:id="_key3zE2">These need regular review," "Healthy eating means at least 5 serves of vegetables &amp; 2 serves of fruit every day," "Did you know that some diabetes medications can help with weight loss?</s><s xml:id="_CR9Ccev">Talk to your Doctor to see if these are options for you," "Activity can be accumulated in shorter bouts of 10 minutes each," and "Try steaming, baking or grilling to reduce the need for oil when cooking."</s><s xml:id="_hJ4psMF">The number of messages addressing various topics is provided in Table <ref type="table" target="#tab_0">S1</ref> in Multimedia Appendix 1.</s><s xml:id="_F27mSnY">All messages concluded with a sign-off indicating that it was from the SupportMe program and the hospital team that the participant was primarily associated with.</s></p><p xml:id="_VpaBpVz"><s xml:id="_2ptVN6Y">Messaging was unidirectional with no expectation of return messages, but these were monitored by a researcher.</s><s xml:id="_BBdUYsz">Where return messages suggested potential clinical concern, they were escalated to a physician for review.</s><s xml:id="_632r9kh">This researcher did not participate in the data collection or analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_J9AyJUx">Randomization</head><p xml:id="_yQgNz9e"><s xml:id="_xS8AEzF">Computerized randomization was conducted in-house using a randomization function from the Xojo framework (Xojo, Inc).</s><s xml:id="_Z2buB94">This occurred with a uniform allocation of 1:1 (block size 8) stratified by health condition (T2D, CHD, or both).</s><s xml:id="_5p9U4Dr">Randomization automatically occurred following the baseline study visit and entry of baseline data into a secure REDCap (Research Electronic Data Capture; Vanderbilt University) web interface.</s><s xml:id="_EuSUaTR">The computerized platform connected to the SMS text messaging platform to send messages to the intervention participants automatically based on randomization.</s><s xml:id="_qh3WRet">To minimize unblinding at follow-up, all participants were sent a message requesting them not to reveal treatment allocation to the data collectors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_q9mz2j2">Blinding</head><p xml:id="_RCJEERn"><s xml:id="_57xkrZq">The study was single-blinded.</s><s xml:id="_NNwtAd9">Participants were aware of whether they had received the SMS text messaging intervention.</s><s xml:id="_ZFDSQC7">However, the study personnel collecting the data and the statistician were blinded to group allocation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_GKSPftY">Data Collection</head><p xml:id="_snbbKZc"><s xml:id="_AF2PgEk">Participants were assessed face to face at baseline and at 6 months.</s><s xml:id="_uYFGZYv">This occurred in hospital and private clinic settings.</s><s xml:id="_S85Pp8M">BP, heart rate, weight, height, and waist circumference were measured.</s><s xml:id="_eDubXRb">Questionnaires assessed physical activity (Global Physical Activity Questionnaire) <ref type="bibr" target="#b21">[22]</ref>, dietary intake (combination of the dietary component of the World Health Organization stepwise approach to noncommunicable disease risk factor surveillance and the diet questionnaire from the TEXT ME study [Multimedia Appendix 2]) <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b22">23]</ref>, quality of life (12-item Short Form Health Survey) <ref type="bibr" target="#b23">[24]</ref>, depression (Patient Health Questionnaire-9 depression scale) <ref type="bibr" target="#b24">[25]</ref>, smoking status, and medication use.</s></p><p xml:id="_g2FCzRX"><s xml:id="_TKQM8ZX">The Global Physical Activity Questionnaire collects physical activity data in 3 domains: activity at work, travel to and from places, and recreational activity.</s><s xml:id="_DrsNEct">The work and recreational activity domains ask about vigorous-and moderate-intensity activities, whereas the travel domain only records moderate-intensity activity.</s><s xml:id="_GFBR9pJ">The total physical activity is given as the number of metabolic equivalent of task (MET) minutes per week.</s><s xml:id="_2ek8FmK">This was calculated by multiplying the total minutes of vigorous activity undertaken in a typical week by 8 and the total minutes of moderate-intensity activity undertaken per week by 4 and then adding these 2 figures <ref type="bibr" target="#b21">[22]</ref>.</s></p><p xml:id="_ueRnwHF"><s xml:id="_mMPMd7G">Our dietary questionnaire was a food frequency questionnaire that assessed the consumption of fruits, vegetables, fish, oil, and salt (Multimedia Appendix 2).</s><s xml:id="_5ZtZBZt">Weekly fruit consumption was determined by multiplying the number of servings eaten on a typical day by the number of days in a typical week in which fruit was eaten.</s><s xml:id="_KzQXnZY">Weekly vegetable consumption was determined by multiplying the number of servings eaten on a typical day by the number of days in a typical week in which vegetables were eaten.</s><s xml:id="_KvBGkGB">Fish consumption was determined by asking how many grams of fish were eaten in a typical week.</s><s xml:id="_ATRFKSP">The questionnaire also asked how many meals per week were eaten that were not prepared at home.</s><s xml:id="_ZUS7ccE">The SF-12 was used to assess quality of life, with physical and mental components.</s><s xml:id="_qSQ5A4f">A score was generated by applying the proprietary algorithm used by QualityMetric <ref type="bibr" target="#b13">[14]</ref>.</s><s xml:id="_ZcECcz2">Higher scores indicate better physical and mental health functioning.</s><s xml:id="_fBNsvhV">The Patient Health Questionnaire-9 depression scale was used to assess the depression score.</s><s xml:id="_wtcRmQm">It comprises 9 Likert-scale questions ranging from 0 to 3 that are summed so that the minimum score is 0 and the maximum score is 27.</s><s xml:id="_Q59uB9v">A higher score indicates a greater degree of depression, with a score of 1 to 4 indicating minimal depression and a score of 20 to 27 being indicative of severe depression.</s></p><p xml:id="_X4TpT9z"><s xml:id="_DfuVgcM">Fasting total cholesterol, LDL-C, high-density lipoprotein cholesterol, triglyceride, and fasting glucose levels were obtained, as well as HbA 1c level for those with diabetes.</s><s xml:id="_hj5wvAd">For participants unable to return for the 6-month assessment, partial data collection was obtained via telephone and review of medical records.</s><s xml:id="_q2s6qqg">As this was a pragmatic trial, routine blood tests organized by participants' health professionals were accepted.</s></p><p xml:id="_sVMA69N"><s xml:id="_kVbXeGT">Serious adverse events related to diabetes or CHD were adjudicated by physicians independently from the study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_q4r3rnC">Outcomes</head><p xml:id="_4TQCxAR"><s xml:id="_XqGy7fV">Systolic BP (SBP) was chosen as the primary outcome at 6 months as this is an important modifiable risk factor common to patients with both CHD and T2D.</s><s xml:id="_UhEYYkD">Secondary outcomes included diastolic BP (DBP), BMI, waist circumference, fasting LDL-C level, fasting glucose level, physical activity, dietary intake, quality of life, depression score, smoking cessation, and if any medications were missed in the previous 30 days.</s><s xml:id="_hdswZwF">Participants with T2D were evaluated for HbA 1c level.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Sm8P6WQ">Process Evaluation</head><p xml:id="_Zpr9fNW"><s xml:id="_vVg4MHQ">We followed our previous methodology of process evaluation <ref type="bibr" target="#b10">[11]</ref>.</s><s xml:id="_QppdDBj">The implementation of the intervention was monitored using screening logs along with a log of study interactions with participants.</s><s xml:id="_Rsc6d3k">At the 6-month time point, all intervention participants were administered a survey that explored the acceptability, suitability, engagement, and perceived utility of the SMS text messages.</s></p><p xml:id="_7cgj2vK"><s xml:id="_ckWuCRE">Participants allocated to the intervention group (who provided consent to participate in further research) were also consecutively invited to participate in a focus group discussion.</s><s xml:id="_9erpzAN">The number of focus groups was determined by thematic saturation, with a target of 6 to 10 participants per focus group.</s><s xml:id="_qw3sA2Q">The in-person focus group discussions (1.5-hour duration) were conducted according to usual processes, were facilitated by an experienced researcher (RH), and were audio recorded and transcribed.</s><s xml:id="_t9Dyrzy">Focus groups were facilitated according to a discussion guide that explored key topics, including participant perceptions of the texting program and its utility along with barriers to and enablers of its implementation (Table <ref type="table" target="#tab_1">S2</ref> in Multimedia Appendix 1).</s><s xml:id="_R6x8j8B">For the analysis, the demographic information of the focus group participants was summarized using means and proportions.</s><s xml:id="_E3PYPtd">The analysis was thematic, with transcriptions coded by a clinician researcher.</s><s xml:id="_7qfsStT">Representative direct quotes were then selected to illustrate themes.</s></p><p xml:id="_fD48PdV"><s xml:id="_HAMbUpz">The study planned to recruit 1000 participants as sample size calculations estimated that this number would enable detection of a 3.5 mm Hg difference in SBP with 80% power and 20% loss to follow-up (type-1 error of 5% and 2-sided α assuming an SD of 17 mm Hg).</s><s xml:id="_A4BjT5V">A sample size of 625 patients with diabetes allowing for 20% dropout had 80% power to detect a difference of 0.3% in HbA 1c level (SD of 1.2% based on local data <ref type="bibr" target="#b25">[26]</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KG4cKk3">Statistical Methods</head><p xml:id="_KfAynPC"><s xml:id="_x7hYFhg">We followed a prespecified statistical analysis plan and intention-to-treat principles.</s><s xml:id="_MZ6NTdF">Baseline continuous variables were presented as means and SDs.</s><s xml:id="_b6uVcGX">Survey data were summarized by proportions.</s><s xml:id="_KxR5WRy">Outcome comparisons were presented as adjusted means or relative risks, and 95% CIs between treatment groups were calculated using regression models adjusting for the baseline measure of that specific outcome.</s><s xml:id="_DH4nWdJ">For dichotomous outcomes, log-binomial regression was used, and for continuous outcomes, linear regression was used.</s><s xml:id="_umsWjxh">Analyses were conducted using R (version 3.5.2;</s><s xml:id="_kgW5CEV">R Foundation for Statistical Computing) packages.</s><s xml:id="_brf4jJk">Statistical tests were 2-tailed, with a 5% significance threshold.</s></p><p xml:id="_YCraKqE"><s xml:id="_35KxaHB">Although endeavoring to capture outcome data within 1 month of the 6-month time point, we prespecified that results obtained 4 to 13 months after randomization were acceptable but as protocol deviations.</s><s xml:id="_T6EEVzp">As this was a pragmatic trial, the exact timing of the outcome assessment could not be controlled as it was based on routine care.</s><s xml:id="_tppvRXP">A sensitivity analysis that restricted the data to results from 5 to 8 months after randomization found no impact on the final conclusions.</s></p><p xml:id="_zZ2HqwW"><s xml:id="_PTsQuEz">Differences in the effect of the intervention on the primary outcome (SBP) for subgroups were explored using prespecified risk factors.</s><s xml:id="_nhPy9FX">A similar prespecified analysis was undertaken for HbA 1c level.</s><s xml:id="_Zxv8YXY">Subgroup analyses were conducted for the participants with diabetes and for those with CHD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Wb2UQYU">Ethics Approval</head><p xml:id="_cc8mwTp"><s xml:id="_D8hdzh6">This study was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12616001689460) and approved by the WSLHD Human Research Ethics Committee (AU RED HREC/16/WMEAD/331).</s><s xml:id="_x9HMXPp">All participants provided written consent.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_C6bJ8X2">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dueVqsp">Participant Characteristics</head><p xml:id="_TtX22xb"><s xml:id="_dsHmHfz">Between May 2017 and April 2019, a total of 1341 participants were referred to the study, of whom 439 (32.74%) were excluded as they did not meet all study criteria or declined to participate and 902 (67.26%) were randomized (n=448, 49.7% to the intervention group and n=454, 50.3% to the control group).</s><s xml:id="_KJR3Myd">A total of 96.5% (870/902) of participants reached the 6-month follow-up with at least partial data completion, and primary outcome data were obtained for 89.5% (807/902) of the participants (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_5HSb5wP">Recruitment ceased early because of budget constraints and meeting the number of participants with diabetes as per the secondary sample size calculations.</s></p><p xml:id="_5ka3qZw"><s xml:id="_VRGtKKx">Of the 902 participants, 260 (28.8%) received the CHD-only program, 396 (43.9%) received the T2D-only program, and 246 (27.3%) received the CHD and T2D program.</s><s xml:id="_kWRahk5">A total of 16.5% (43/260) of participants with T2D did not meet the HbA 1c range for study inclusion but had CHD, so they received the CHD-only program.</s><s xml:id="_H9Mkbd7">There were 0.4% (4/902) of participants who had type 1 diabetes.</s><s xml:id="_YygsubV">They were included in the CHD-only program.</s><s xml:id="_38sY9Z8">The mean participant age was 61.5 (SD 11.6) years, and 28.5% (257/902) were women.</s><s xml:id="_GrYFkSt">The mean baseline SBP was 129 (SD 17) mm Hg, mean baseline DBP was 78 (SD 10) mm Hg, mean baseline BMI was 32.0 (SD 7.1) kg/m 2 , mean baseline LDL-C level was 2.0 (SD 0.9) mmol/L, mean baseline fasting glucose level was 8.2 (SD 3.2) mmol/L, and mean baseline HbA 1c level was 8.4% (SD 1.3%).</s><s xml:id="_Whg3vnP">Baseline characteristics were similar between the groups (Table <ref type="table" target="#tab_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_xwd5FHP">Effect of the Intervention on the Primary Outcome</head><p xml:id="_kXDGBAw"><s xml:id="_e7VH4BQ">There was no difference in SBP between the groups at the 6-month assessment when adjusted for baseline SBP (adjusted mean difference=0.9</s><s xml:id="_cXyZnaC">mm Hg, 95% CI -1.1 to 2.9; P=.38; Table <ref type="table" target="#tab_1">2</ref>).</s><s xml:id="_bG9QUDn">The prespecified analyses demonstrated no treatment interaction with baseline SBP, diabetes status, CHD status, LDL-C level, age, gender, education status, smoking status, BMI, or ethnicity (Figure <ref type="figure" target="#fig_3">2</ref>).</s><s xml:id="_yv37adY">.79</s><s xml:id="_PZkX9aR">-0.0 (-0.3 to 0.3) a 1.7 (1.5 to 1.9) 1.7 (1.5 to 1.9) Meals not prepared at home eaten per week, adjusted mean (95% CI) .05</s><s xml:id="_3rKvZfE">0.9 (0.9 to 1.0) b 270 (73) h 294 (78.8) g Using butter or ghee for cooking, n (%) .42</s><s xml:id="_mT2MMKe">0.9 (0.7 to 1.</s></p><p xml:id="_GZpQMRW"><s xml:id="_x4ddQtU">2) b 21 (70) k 26 (78.8) j Continued current smokers i , n (%) .82</s><s xml:id="_fAmKNp4">0.1 (-0.9 to 1.2) a 46.6 (45.8 to 47.3) 46.5 (45.7 to 47.2) Quality of life: physical component summary, adjusted mean (95% CI) .24</s><s xml:id="_ssPu2sc">0.5 (-0.3 to 1.3) a 49.3 (48.8 to 49.9) 48.8 (48.3 to 49.4) Quality of life: mental component summary, adjusted mean (95% CI)</s></p><p xml:id="_S2vWKGK"><s xml:id="_Ee5Ptjq">.67 -0.1 (-0.8 to 0.5) a 5.5 (5.0 to 5.9) 5.6 (5.2 to 6.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_3gF6dty">Effect of the Intervention on the Secondary Outcomes</head><p xml:id="_YDhFXv4"><s xml:id="_7xQuJaJ">There were no significant differences between the groups in BMI, waist circumference, DBP, LDL-C level, and fasting glucose level at the 6-month assessment (Table <ref type="table" target="#tab_1">2</ref>).</s><s xml:id="_NqjFRCG">There was also no difference between the groups in physical activity, diet, depressive symptoms, and quality of life.</s><s xml:id="_mSu5drH">Fewer participants in the intervention group reported missed medication on at least one of the last 30 days (relative risk=0.82,</s><s xml:id="_4Pq8WH4">95% CI 0.68-1.00;</s><s xml:id="_xnK3MyW">P=.045).</s><s xml:id="_fZctTEt">There was greater fish consumption in the intervention group by 41 g per week (95% CI 12-70; P=.004).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5D4kPB8">T2D Subgroup Analysis</head><p xml:id="_dTPg8q6"><s xml:id="_nTDxSze">A subgroup analysis was conducted to examine the effect of the intervention on people with T2D, that is, those in the T2D and combined T2D and CHD groups.</s><s xml:id="_jSgDcYv">The characteristics of the participants with T2D are listed in Table <ref type="table" target="#tab_3">3</ref>, and the outcomes of the trial in this group are detailed in Table <ref type="table" target="#tab_5">4</ref>.</s><s xml:id="_mNVZcWp">There was no difference in the primary outcome (SBP) between the intervention and control groups at the 6-month assessment (adjusted mean difference=1.2</s><s xml:id="_KJYH7sn">mm Hg, 95% CI -1.1 to 3.6; P=.31).</s><s xml:id="_G5ya7Tx">There was a reduction in mean HbA 1c level from 8.4% (SD 1.3%) at baseline to 7.7% (SD 1.4%) in the intervention participants and to 7.8% (SD 1.4%) in the control participants (reduction from mean 68, SD 14 mmol/mol to mean 61, SD 15 mmol/mol and mean 62, SD 15 mmol/mol, respectively; Table <ref type="table" target="#tab_3">3</ref>).</s><s xml:id="_KGJAJ5R">However, the difference in HbA 1c level at the 6-month assessment between the intervention and control arms was not significant (adjusted mean difference=0.1%,</s><s xml:id="_bv4MZNn">95% CI -0.1% to 0.3%; P=. <ref type="bibr" target="#b34">35)</ref>.</s><s xml:id="_xv2a4Nv">Prespecified analyses related to HbA 1c level did not demonstrate that the intervention was more effective for any subgroup based on baseline HbA 1c level, CHD, SBP, LDL-C level, age, gender, education status, smoking status, BMI, or ethnicity (Figure <ref type="figure" target="#fig_7">3</ref>).</s></p><p xml:id="_napCAUn"><s xml:id="_Ndg772S">The increase in fish intake remained significant in the T2D subgroup analysis.</s><s xml:id="_f6YNbru">There was no difference in missed medication between the intervention and control participants.</s><s xml:id="_5gHPbn8">2.0 (0.9) 1.9 (0.9) 2.0 (0.9) LDL s cholesterol (mmol/L), mean (SD)</s></p><p xml:id="_BBb8dwD"><s xml:id="_NdV6S9F">1.1 (0.3) 1.1 (0.3) 1.1 (0.3) HDL t cholesterol (mmol/L), mean (SD) Total Intervention (n=319) Control (n=323) 4.1 (1.2) 4.0 (1.2) 4.1 (1.2) Total cholesterol (mmol/L), mean (SD) 2.2 (2.0) 2.1 (1.5) 2.2 (2.4) Triglycerides (mmol/L), mean (SD) 9.2 (3.3) 9.1 (3.0) 9.3 (3.5) Fasting glucose (mmol/L), mean (SD) 8.5 (1.3) 8.5 (1.4) 8.5 (1.3) HbA 1c u (%), mean (SD) 68 (14) 68 (14) 68 (14) HbA 1c (mmol/mol), mean (SD) Antihypertensive and diabetes medication, n (%) 170 (26.5) 88 (27.6) 82 (25.4) ACE v inhibitors 198 (30.8) 94 (29.5) 104 (32.2) Angiotensin 2 receptor blockers 67 (10.4) 35 (11) 32 (9.9)</s><s xml:id="_NM8xYD9">Thiazide diuretics 207 (32.2) 106 (33.2) 101 (31.3) β-blockers 144 (22.4) 70 (21.9)</s><s xml:id="_yre7y3k">74 (22.9)</s><s xml:id="_nhzZNVJ">Calcium channel blockers 104 (16.2) 61 (19.1) 43 (13.3)</s><s xml:id="_Z2zX2t7">Other antihypertensives 503 (78.3) 256 (80.3) 247 (76.5)</s><s xml:id="_DagCW5P">Metformin 161 (25.1) 80 (25.1) 81 (25.1)</s><s xml:id="_vnXZHHA">Sulfonylureas 116 (18.1) 54 (16.9) 62 (19.2) DPP w -4 inhibitors 174 (27.1) 99 (31) 75 (23.2) SGLT x -2 inhibitors 5 (0.8) 4 (1.3) 1 (0.3) α-glucosidase 67 (10.4) 29 (9.1) 38 (11.8)</s><s xml:id="_rVpDgYk">GLP y -1 agonists 317 (49.4) 159 (49.8) 158 (48.9)</s><s xml:id="_VqMEgFe">Insulin a CHD: coronary heart disease.</s><s xml:id="_bFFSnVw">b n=133.</s><s xml:id="_psYrUj6">c n=127.</s><s xml:id="_sCJf8Aj">d n=260.</s><s xml:id="_bH2XFAA">e CABG: coronary artery bypass graft.</s><s xml:id="_gyhgnGB">f PCI: percutaneous coronary intervention.</s><s xml:id="_vXJqeju">g n=322.</s><s xml:id="_dBjcr8U">h n=316.</s><s xml:id="_TmYMwXH">i n=638.</s><s xml:id="_PWqcR4G">j n=639.</s><s xml:id="_S99kteB">k n=321.</s><s xml:id="_qSyuq9Q">l n=317.</s><s xml:id="_3uXK9MV">m GP: general practice.</s><s xml:id="_DAFmXSz">n n=318.</s><s xml:id="_BcMey5t">o n=640.</s><s xml:id="_wmsMBV6">p MET: metabolic equivalent of task.</s><s xml:id="_FcbmgYC">q SBP: systolic blood pressure.</s><s xml:id="_hcZHG6R">r DBP: diastolic blood pressure.</s><s xml:id="_WuEgN2f">s LDL: low-density lipoprotein.</s><s xml:id="_YHqWq2K">t HDL: high-density lipoprotein.</s><s xml:id="_Tt5dDgV">u HbA 1c : glycated hemoglobin.</s><s xml:id="_reZ3t2c">v ACE: : angiotensin-converting enzyme.</s><s xml:id="_twGejtJ">w DPP: dipeptidyl peptidase.</s><s xml:id="_3zkHsfg">x SGLT: sodium-glucose cotransporter.</s><s xml:id="_QX3PEV8">y GLP: glucagon-like peptide.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NEU5HTD">Fish consumption (grams per week), adjusted mean (95% CI)</head><p xml:id="_Emz9zkN"><s xml:id="_EJTGByx">.65 0.1 (-0.4 to 0.3) b 1.6 (1.4 to 1.9) 1.7 (1.5 to 1.9) Meals not prepared at home eaten per week, adjusted mean (95% CI) .09</s><s xml:id="_6EmzUfq">0.9 (0.9 to 1.0) c 189 (74.1) h 214 (78.4) g Using butter or ghee for cooking, n (%) .31</s><s xml:id="_xpB4MsP">1.1 (0.9 to 1. .64 -0.2 (-1.0 to 0.6) b 5.9 (5.3 to 6.5) 6.1 (5.5 to 6.6) Depression score (PHQ-9 m ), adjusted mean (95% CI) .30</s><s xml:id="_BsBn8F8">0.9 (0.7 to 1.1) c 83 ( <ref type="formula">30</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_XTJNbnK">CHD Subgroup Analysis</head><p xml:id="_G4eD8sJ"><s xml:id="_upqKHwk">A subgroup analysis was conducted to examine the effect of the intervention on people with CHD, that is, those in the CHD and combined T2D and CHD groups.</s><s xml:id="_vyz6dMe">The characteristics of the participants with CHD are listed in Table <ref type="table" target="#tab_6">5</ref>, and the outcomes of the trial in this group are detailed in Table <ref type="table">6</ref>.</s><s xml:id="_mN5y3WH">There was no difference in the primary outcome (SBP) between the intervention and control groups at the 6-month assessment (adjusted mean difference=0.8</s><s xml:id="_m6XyuWm">mm Hg, 95% CI -1.9 to 3.5; P=.55).</s></p><p xml:id="_GthP2Mg"><s xml:id="_rH7zvW8">The increase in fish intake remained significant in the CHD subgroup analysis.</s><s xml:id="_nSTWQpk">There was also a decrease in the use of butter or ghee for cooking.</s><s xml:id="_8Wa9gJT">The reduction in missed medication was borderline significant (P=.05).</s><s xml:id="_Krr2ky8">1.9 (0.9) 1.9 (0.9) 1.9 (0.8) LDL n cholesterol (mmol/L), mean (SD) 1.1 (0.3) 1.1 (0.3) 1.1 (0.3) HDL o cholesterol (mmol/L), mean (SD) Total Intervention (n=256) Control (n=250) 3.9 (1.1) 3.9 (1.1) 3.9 (1.1)</s><s xml:id="_wNtHXkr">Total cholesterol (mmol/L), mean (SD)</s></p><p xml:id="_TgtBPkN"><s xml:id="_UeSwhPs">1.9 (1.8) 1.8 (1.2) 2.0 (2.3) Triglycerides (mmol/L), mean (SD) 7.3 (3.0) 7.1 (2.7) 7.6 (3.2) Fasting glucose (mmol/L), mean (SD) Antihypertensive medication, n (%) 190 (37.5) 98 (38.3) 92 (36.8)</s><s xml:id="_wtM26Uw">ACE p inhibitors 140 (27.7)</s><s xml:id="_qBbeVvV">74 (28.9) 66 (26.4) Angiotensin 2 receptor blockers 43 (8.5) 23 (9) 20 (8) Thiazide diuretics 286 (56.5) 149 (58.2) 137 (54.8) β-blockers 117 (23.1) 65 (25.4) 52 (20.8)</s><s xml:id="_uVT7eJs">Calcium channel blockers 80 (15.8) 44 (17.2) 36 (14.4)</s><s xml:id="_UDRHqD8">Other antihypertensives a CABG: coronary artery bypass graft.</s><s xml:id="_um2brVY">b PCI: percutaneous coronary intervention.</s><s xml:id="_SdGYQKn">c n=249.</s><s xml:id="_8xGDkG5">d n=254.</s><s xml:id="_PTjxrC6">e n=503.</s><s xml:id="_8V3hEYu">f n=252.</s><s xml:id="_nrrWDxc">g n=502.</s><s xml:id="_heNrtZZ">h GP: general practice.</s><s xml:id="_hQUsnNC">Waist circumference (cm), adjusted mean (95% CI) .10</s><s xml:id="_DRF6PCh">0.1 (0.0 to 0.3) b 1.9 (1.9 to 2.0) 1.7 (1.6 to 2.0) LDL d cholesterol (mmol/L), adjusted mean (95% CI) .88</s><s xml:id="_DyuUzeY">0.0 (-0.5 to 0.6) b 6.9 (6.6 to 7.3) 6.9 (6.5 to 7.3) Fasting glucose (mmol/L), adjusted mean (95% CI) .14</s><s xml:id="_g8ZkmUh">364 (-121 to 849) b 2108 (1766 to 2450) 1744 (1402 to 2089) Total physical activity (MET e minutes per week), adjusted mean (95% CI) .90</s><s xml:id="_AbBD4CC">0.1 (-1.2 to 1.4) b 10.9 (10.0 to 11.9) 10.8 (9.9 to 11.8) Fruit consumption (servings per week), adjusted mean (95% CI) .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CNNYbD8">Process Measures</head><p xml:id="_XcW7rmt"><s xml:id="_MGd2uuW">In total, 76.8% (344/448) of the intervention participants responded to the feedback questionnaire.</s><s xml:id="_t4v7hvJ">Most respondents reported that the SMS text message support program was useful (298/344, 86.6%); easy to understand (336/344, 97.7%); and appropriate in terms of language, number of messages, and program length (Table <ref type="table">7</ref>).</s><s xml:id="_zmwGy9x">There was a high level of engagement, as reflected by the 92.4% (318/344) who read at least three-quarters of their messages and the 54.4% (187/344) who showed the messages to family and friends.</s><s xml:id="_GG8qga9">Furthermore, most respondents (217/344, 63.1%) agreed that the messages motivated change, and 59.3% (204/344) indicated that the messages reminded them to take their medication (Table <ref type="table">7</ref>).</s></p><p xml:id="_GzxwvcF"><s xml:id="_r7tpAE5">Table <ref type="table">7</ref>. Summary of utility and perceived acceptability of SMS text message support among 334 intervention participants.</s><s xml:id="_fPwppjn">Response options were "Strongly agree," "Agree," "Neutral," "Disagree," and "Strongly disagree" for the first 6 items and final item.</s><s xml:id="_6WHMe4q">We report the proportion for "Agree" and "Strongly agree."</s><s xml:id="_Tw52SP4">For the first 3 questions regarding message characteristics, we report the percentage of participants who answered.</s></p><p xml:id="_GxkGCfy"><s xml:id="_6kQRGZR">Agree or Strongly Agree Question Process Grouping Usefulness and understanding • • 298/344 (86.6%)</s><s xml:id="_gW3SGVN">Found messages useful • • Messages were easy to understand 336/344 (97.7%)</s><s xml:id="_mRSz2Sm">Influence on motivation and behavior change • • 217/344 (63.1%)</s><s xml:id="_BFZzphq">Messages motivated change • • Diet more healthy because of messages 209/344 (60.8%) • • 168/344 (48.8%)</s><s xml:id="_vy2FQ44">Exercise increased because of messages • • Messages reminded them to take their medicines 204/344 (59.3%)</s><s xml:id="_t4j5y9X">Message saving and sharing • • 318/344 (92.4%)</s><s xml:id="_zF7McuH">Read at least three-fourths of messages • • Deleted messages 47/344 (13.7%) • • 273/344 (79.3%)</s><s xml:id="_GhWeW96">Saved messages • • Showed messages to family or friends 187/344 (54.4%) • • 41/344 (11.9%)</s><s xml:id="_xSPuEpA">Forwarded messages to family or friends Appropriate message characteristics • • 311/344 (90.4%)</s><s xml:id="_f994DEr">Message language was appropriate • • Number of messages per week was appropriate 300/344 (87.2%) • • 295/344 (85.8%)</s><s xml:id="_pvWNZXW">Program length was appropriate • • Time of day messages received was appropriate 258/344 (75.0%)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7r8TVND">Focus Groups</head><p xml:id="_hmpcbDh"><s xml:id="_KGva47g">A total of 4.9% (16/325) men and 1.6% (2/129) women from the intervention arm, with a mean age of 62.4 (SD 10.3) years, participated in the focus groups after completing the 6-month program.</s><s xml:id="_WBC5gX9">Thematic analysis demonstrated that participants identified 5 enablers in the program: active reminders to lead a healthy lifestyle, encouragement of dietary changes, encouragement of more physical activity, the ability to share the messages with friends and family, and the feeling of support that the program offered.</s><s xml:id="_XpRGQwM">There was consensus that the content of the messages was appropriate and pitched at the right level.</s><s xml:id="_uadzMu4">The content on physical activity and diet was considered particularly helpful.</s><s xml:id="_rRgzEqd">Responses illustrating these themes are provided in Table <ref type="table" target="#tab_3">S3</ref> in Multimedia Appendix 1.</s><s xml:id="_dheYBXK">The 2 main barriers identified were the unidirectional nature of the messages-and, therefore, the lack of interaction with a health professional-and the fact that the messages were insufficiently detailed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_y6FbTW5">Adverse Events</head><p xml:id="_fuqyNGm"><s xml:id="_bKvVRFq">There were 6.4% (29/454) of adjudicated hospital events among the intervention participants and 6.3% (28/448) among the control participants (P=.93).</s><s xml:id="_Ztsd9cc">There were 9 deaths-5 (56%) in the intervention group and 4 (44%) in the control group.</s><s xml:id="_x4SNsGm">No adverse events or deaths were deemed related to the intervention.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vdKsVPn">Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_VejnuKC">Principal Findings</head><p xml:id="_c6qDEZM"><s xml:id="_YGNxdam">Maintaining a connection with patients with chronic diseases is a challenge, but it is an important aspect of care as self-management support can prevent or moderate exacerbations.</s><s xml:id="_HBSXmVs">The SupportMe study is the largest RCT to date of an SMS text messaging program providing support for healthy lifestyle and chronic disease self-management and with the largest number of people with diabetes.</s><s xml:id="_77uUPVQ">Novel aspects of this study include the customization of the program to suit people with one or both of the diseases that were the focus-T2D and CHD-and the establishment of the study within the context of a health district-wide chronic disease integrated care program.</s><s xml:id="_u6Yx5UK">The study indicates that a program to support patients with chronic diseases using educational and motivational messages is feasible, well received, and engaging.</s><s xml:id="_ZkPFQ9a">Widespread implementation is perceived to be beneficial, but as illustrated by the lack of an effect on the primary outcome (SBP) as well as secondary outcomes such as HbA 1c level, implementation cannot assume a significant or immediate impact on clinical risk factors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_nvN84en">Findings in Relation to the Literature</head><p xml:id="_BUsEA9m"><s xml:id="_E5eMcgc">Previous studies using SMS text messaging suggest that this may be effective in supporting patient management and improving clinical risk factors.</s><s xml:id="_t3wHtsS">The earlier TEXT ME study delivered a similar SMS text messaging program to participants with CHD (messages nearly identical to those for participants with CHD in SupportMe) and demonstrated improvements in multiple clinical risk factor measures, including LDL-C level, BP, BMI, physical activity, and smoking cessation <ref type="bibr" target="#b8">[9]</ref>.</s><s xml:id="_MUxz9qE">A meta-analysis of early small studies showed that SMS text messaging programs for people with T2D achieved an overall reduction in HbA 1c level of 0.38% (4 mmol/mol) <ref type="bibr" target="#b12">[13]</ref>.</s><s xml:id="_qkh9n5c">Recent studies with large cohorts-Self-Management Support for Blood Glucose (SMS4BG), Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM), and Rapid Education/Encouragement and Communications for Health-have demonstrated similar small improvements in HbA 1c level of 0.3% to 0.4% (3-4 mmol/mol) <ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref>.</s><s xml:id="_Fw2w4zn">However, another contemporary texting program for people with diabetes in Australia also failed to demonstrate an improvement in HbA 1c level, although there was a similarly high level of program satisfaction and acceptability <ref type="bibr" target="#b26">[27]</ref>.</s></p><p xml:id="_nzk5EFT"><s xml:id="_KxgYHAt">The lack of improvement in clinical metrics in SupportMe may be due to baseline metrics that were within or close to the guideline targets among many participants.</s><s xml:id="_Wk86aur">The mean baseline SBP was 128.9 (SD 17.2) mm Hg, and the mean LDL-C level was 2.0 (SD 0.9) mmol/L.</s><s xml:id="_EkbbPwD">In Australian guidelines, for most people with hypertension, a BP target of &lt;140/90 mm Hg is recommended <ref type="bibr" target="#b27">[28]</ref>.</s><s xml:id="_uctCp9g">For people at high cardiovascular risk, an LDL-C level of &lt;2.0 mmol/L is recommended <ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_NS2Ae46">Therefore, many participants in SupportMe were already at the target BP and lipid levels at baseline.</s><s xml:id="_bBzz57y">In TEXT ME, after 6 months of intervention, the SBP was 128 mm Hg, and the LDL-C level was 2.0 mmol/L, which are similar to our baseline measures <ref type="bibr" target="#b8">[9]</ref>.</s><s xml:id="_8TRXmqp">Only 8.2% (74/902) of the participants in our study were current smokers compared with 53% in TEXT ME <ref type="bibr" target="#b8">[9]</ref> and 41% and 15% in the CHAT-DM and SMS4BG studies, respectively <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b15">16]</ref>.</s><s xml:id="_asns6pg">The baseline HbA 1c level in SupportMe was 8.4% (68 mmol/mol) compared with 9.8% (84 mmol/mol) in SMS4BG <ref type="bibr" target="#b13">[14]</ref>.</s><s xml:id="_psDQbBr">Participants in SupportMe undertook 1898 MET minutes per week of physical activity compared with 380 MET minutes per week in TEXT ME and 1386 MET minutes per week in CHAT-DM <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b15">16]</ref>.</s><s xml:id="_NyFaGQJ">These factors suggest that the SupportMe cohort was more focused on healthy lifestyle behaviors or received better disease management than participants in previous studies.</s><s xml:id="_mKMhwGy">Therefore, there was much less room for the SMS text messages to achieve further improvement.</s></p><p xml:id="_ERN79E8"><s xml:id="_vwBPTxm">The involvement of specialist and hospital teams as part of the WSICP may have contributed to the favorable baseline metrics in SupportMe.</s><s xml:id="_kzjKHvz">GPs who referred community patients had greater engagement in the management of T2D and CHD and were supported by care facilitators who helped with guideline management of patients with these chronic diseases <ref type="bibr" target="#b17">[18]</ref>.</s><s xml:id="_EQKfRtu">Thus, participants were already receiving high-level professional care and support.</s><s xml:id="_MeM2xtN">This is reflected in the decrease in HbA 1c level of 0.6% (7 mmol/mol) in the control arm of SupportMe, which is similar to that of the intervention arm of the SMS4BG study and greater than that of the intervention arm in the CHAT-DM study <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b15">16]</ref>.</s></p><p xml:id="_2aQMVrG"><s xml:id="_wZbs7My">The age of the SupportMe participants, particularly with respect to the participants with diabetes (mean 60.2, SD 11.4 years), might be another factor that influenced the results.</s><s xml:id="_3yQZjSH">The mean age of participants in SMS4BG, Rapid Education/Encouragement and Communications for Health, and CHAT-DM was 47, 56, and 60 years, respectively, so our participants were among the oldest in these studies.</s><s xml:id="_zbR6ek9">The SupportMe CHD participants (mean age 64.0, SD 10.8 years) were also older than the TEXT ME participants (mean age 57 years).</s><s xml:id="_zXU4xWE">Perhaps older patients are less responsive to this mode of engagement as they are less familiar with the regular use of this technology, although our evaluation did indicate that most of the messages were read.</s><s xml:id="_gYAgQzd">It would be interesting to test a similar SMS text messaging program for a younger population with multiple chronic diseases.</s><s xml:id="_VMzyyRw">Some programs have incorporated return messages from participants, which may improve interaction and engagement <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15]</ref>.</s><s xml:id="_7gs3EAm">Our focus groups identified the lack of bidirectional messaging as a barrier.</s><s xml:id="_64V2BuJ">A meta-regression analysis of telemedicine trials for diabetes found that interventions that included provider-to-patient messaging and those in which providers adjusted medication in response to data from patients were more effective <ref type="bibr" target="#b28">[29]</ref>.</s><s xml:id="_d55HF6h">However, this requires considerably more resources and day-to-day clinician involvement.</s><s xml:id="_Anr4K24">Widespread implementation of such a model is not feasible in most health systems.</s><s xml:id="_3A38pg9">The focus groups also revealed a desire for more detailed information, which was difficult to provide in a short SMS text message.</s><s xml:id="_5hgE52K">Future programs with internet-connected phones can overcome this with increased use of embedded web links.</s></p><p xml:id="_sUE8wK4"><s xml:id="_JzzuxeN">We found better self-reported medication adherence with the SMS text messaging intervention.</s><s xml:id="_xDYKD4w">This is consistent with other studies, with a meta-analysis of 16 RCTs showing that SMS text messaging is effective in increasing medication adherence independently of whether 2-way communication is used <ref type="bibr" target="#b7">[8]</ref>.</s><s xml:id="_MzJPmUz">Perhaps the relatively large number of messages related to medication in SupportMe (16 to 18 depending on health condition, with an additional 5 for those treated with insulin) contributed to an improvement in medication adherence.</s><s xml:id="_XSdj8kg">Notably, the reduction in missed medication was significant in the CHD subgroup but not in the diabetes subgroup.</s><s xml:id="_78b5eJE">It is possible that complex diabetes medication regimens are a greater barrier to full adherence.</s><s xml:id="_bWeef2b">Improving medication adherence is nonetheless challenging, with a similar trial conducted by our group failing to demonstrate that supportive SMS text messages improve medication adherence among patients following acute coronary syndromes <ref type="bibr" target="#b29">[30]</ref>.</s></p><p xml:id="_AK9tX2d"><s xml:id="_pgNpZTh">Although we did not find an improvement in short-term clinical metrics, the high levels of engagement and acceptability may have other positive implications.</s><s xml:id="_nhz27gF">Patient engagement and activation have been linked to better health outcomes and patient experience and reduced health care costs <ref type="bibr" target="#b30">[31]</ref>.</s><s xml:id="_Tugav9T">Engaged patients are more likely to participate in healthy behaviors and seek and use health information <ref type="bibr" target="#b30">[31]</ref>.</s><s xml:id="_EuXC5QW">For the population involved in SupportMe with T2D or CHD, this may translate into less long-term demand on the highly specialized and limited workforce in these fields.</s></p><p xml:id="_GtR7FVR"><s xml:id="_sDmbT7y">A limitation of this study was the failure to reach the planned sample size for the primary outcome.</s><s xml:id="_PC9bfR3">However, it is unlikely that recruitment of an extra 98 participants would have changed the results to be significantly in favor of the intervention.</s><s xml:id="_DWbGRdV">It was also disappointing that primary outcome data could not be obtained for 10.5% (95/902) of the participants.</s><s xml:id="_veXvneq">Although many participants were very engaged, there was also a group in which engagement and follow-up were challenging.</s><s xml:id="_Nvq3BX6">Arguably, these are the patients who most require support, and SMS text messaging may not be the optimal means of achieving this.</s><s xml:id="_NhMgrKj">Finally, we accepted blood test results ordered from a range of clinicians performed in different laboratories.</s><s xml:id="_ssRYVvZ">In some cases, clinical metrics for participants who were unable to return for review were obtained from their primary physicians.</s><s xml:id="_RKRG2Sd">Thus, laboratory testing and some physical measurements were not standardized.</s></p><p xml:id="_8HsP2nb"><s xml:id="_5ZGcKFt">The question of whether the SMS text messages could have been better formulated is a vital one.</s><s xml:id="_U7maWaA">The messages were developed through a proven and rigorous process <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b31">32]</ref>, and many had been used in a previous trial where SMS text messaging was successful in improving clinical metrics <ref type="bibr" target="#b8">[9]</ref>.</s><s xml:id="_uXp7e6a">We have also recently demonstrated that similar healthy lifestyle messages prompt an increase in physical activity among women at risk of diabetes <ref type="bibr" target="#b32">[33]</ref>.</s><s xml:id="_2SdEywt">Nonetheless, further development and testing of messages for any similar program would be desirable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KpTWkVq">Conclusions</head><p xml:id="_ddD7ftM"><s xml:id="_345SbNu">Mobile phone ownership is very high in many countries, even in low-and middle-income countries.</s><s xml:id="_Wqqm6X4">This enables the delivery of health messages to a large population group, overcoming access barriers at a low cost.</s><s xml:id="_FY3VSt3">The telecommunications cost of delivering 4 SMS text messages per week for 6 months was in the order of Aus $6 (US $4.05) per participant.</s><s xml:id="_fdNFXPT">Thus, there is increasing interest in digital health interventions.</s><s xml:id="_Ky6UbYE">SMS text messaging has also been trialed as an adjunct to routine care for people with a range of other chronic diseases other than CHD and diabetes, including chronic kidney disease <ref type="bibr" target="#b33">[34]</ref>, asthma <ref type="bibr" target="#b34">[35]</ref>, hypertension <ref type="bibr" target="#b35">[36]</ref>, and depression <ref type="bibr" target="#b36">[37]</ref>.</s><s xml:id="_7CbS7cV">However, these studies focused on single risk factors or conditions, yet chronic diseases are highly clustered.</s><s xml:id="_nQWk59U">A novel aspect of our program is that we were able to customize it for people with 1 or 2 chronic diseases.</s><s xml:id="_jGvF74Y">As the population with multiple comorbidities increases, having a single SMS text messaging program that has modules for several or a mix of different chronic conditions is preferable to the patient needing to enroll in multiple SMS text messaging programs for different conditions.</s><s xml:id="_xFZcySw">SupportMe has demonstrated the feasibility of this.</s><s xml:id="_M7Qfqzk">It would be important to further test SMS text messaging programs for multiple chronic diseases in populations that are less well supported and have less access to professional care.</s></p><p xml:id="_Ny45GMc"><s xml:id="_rXBHPjK">A key learning from this study is that SMS text messaging programs vary in their effectiveness and utility depending on the precise population and context.</s><s xml:id="_BRUfkEz">Our results do not indicate that SMS text messaging programs are generally ineffective in improving clinical metrics among people with T2D or CHD but that the goal may need to be tailored to the situation.</s><s xml:id="_MvumvBq">Within an integrated care environment where there is already high-level care, SMS text messaging may provide other less tangible benefits.</s><s xml:id="_RZ4EejQ">The co-design process of the SupportMe intervention with a multidisciplinary team and consumers facilitated the development of processes and content for the program as a whole.</s><s xml:id="_eNNGuKB">The high acceptability of the program across participants with multiple conditions indicates that the program can complement routine care by improving the patient experience and sense of engagement, which are important aspects of integrated care.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_NESDuRH"><s xml:id="_ZDhnyfP">Figure 1.</s><s xml:id="_9rAPt3T">CONSORT (Consolidated Standards of Reporting Trials) diagram for the SupportMe randomized controlled trial.</s><s xml:id="_rZ6X2eh">*Excluding 1 participant who was inadvertently randomized twice.</s><s xml:id="_9wEMgjW">CHD: coronary heart disease; HbA 1c : glycated hemoglobin; T2D: type 2 diabetes.</s></p></div></figDesc><graphic coords="5,56.69,376.84,481.92,269.27" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>1 )</head><label>1</label><figDesc><div><p xml:id="_rZNgZDG"><s xml:id="_remfPZn">Depression score (PHQ-9 l ), adjusted mean (95% CI) .045</s><s xml:id="_8zeHet8">0.8 (0.7 to 1.0) b 110 (29.7) h 134 (36.1) m Missed medication on at least one of the last 30 days, n (%) a Adjusted mean difference.</s><s xml:id="_jeCdVsz">b Relative risk.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><figDesc><div><p xml:id="_3jRab56"><s xml:id="_BXszEKs">c LDL: low-density lipoprotein.</s><s xml:id="_YvbSBvf">d HbA 1c : glycated hemoglobin.</s><s xml:id="_MghrY9Y">e Of 642 participants with type 2 diabetes and baseline HbA 1c of 7.1% to 11.4%.</s><s xml:id="_3NCyZ49">f MET: metabolic equivalent of task.</s><s xml:id="_f8ECP5a">g n=373.</s><s xml:id="_zxZamwm">h n=370.</s><s xml:id="_4b7mNa8">i Of 63 participants who were current smokers at baseline.</s><s xml:id="_ezZZy5G">j n=33.</s><s xml:id="_Ph78p6H">k n=30.</s><s xml:id="_hVjx8dv">l PHQ-9: Patient Health Questionnaire-9.</s><s xml:id="_vX4vJ3D">m n=371.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_qE45p3W"><s xml:id="_QJVwV8N">Figure 2. Interaction between subgroups by treatment group for the primary outcome (systolic blood pressure [SBP]).</s><s xml:id="_nKGycK3">GP: general practitioner; LDL: low-density lipoprotein; NZ: New Zealander.</s></p></div></figDesc><graphic coords="10,56.69,92.54,481.90,240.95" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><figDesc><div><p xml:id="_2D2rucn"><s xml:id="_mhmUEXY">-1.0 to 1.4) b 45.8 (45.0 to 46.7) 45.6 (44.8 to 46.5) Quality of life: physical component summary, adjusted mean (95% CI) .23 0.6 (-0.4 to 1.6) b 49.3 (48.6 to 50.0) 48.7 (48.0 to 49.4) Quality of life: mental component summary, adjusted mean (95% CI)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><figDesc><div><p xml:id="_tSkucMA"><s xml:id="_pMfhmUY">) 101(34.6)</s><s xml:id="_UyxuPzB">Missed medication on at least one of the last 30 days, n (%) a Number of participants with data for primary outcome.</s><s xml:id="_Y6ebUfx">b Adjusted mean difference.</s><s xml:id="_7ttxYvM">c Relative risk.</s><s xml:id="_Sk5pddj">d HbA 1c : glycated hemoglobin.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>9 :</head><label>9</label><figDesc><div><p xml:id="_UJPnt6p"><s xml:id="_SkvjcKV">Patient Health Questionnaire-9.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 3 .</head><label>3</label><figDesc><div><p xml:id="_UWystxB"><s xml:id="_vznT9tB">Figure 3. Interaction between subgroups by treatment group for the glycated hemoglobin (HbA 1c ) results at the 6-month assessment among participants with suboptimally controlled type 2 diabetes.</s><s xml:id="_42DXpk4">GP: general practitioner; LDL: low-density lipoprotein; NZ: New Zealander; SBP: systolic blood pressure.</s></p></div></figDesc><graphic coords="14,56.69,94.13,481.90,240.95" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Table 6 .</head><label>6</label><figDesc><div><p xml:id="_qAbtBmp"><s xml:id="_wXymxBh">metabolic equivalent of task.</s><s xml:id="_3TGHmxW">l SBP: systolic blood pressure.</s><s xml:id="_ebHu5G2">m DBP: diastolic blood pressure.</s><s xml:id="_H333h8x">n LDL: low-density lipoprotein.</s><s xml:id="_gv9sVPw">o HDL: high-density lipoprotein.</s><s xml:id="_G3XteV9">p ACE: angiotensin-converting enzyme.</s><s xml:id="_wTtDa4D">J Med Internet Res 2023 | vol. 25 | e38275 | p. 16 https://www.jmir.org/2023/1/e38275</s><s xml:id="_syGrXQx">(page number not for citation purposes) Cheung et al JOURNAL OF MEDICAL INTERNET RESEARCH XSL • FO RenderX Primary and secondary outcomes at the 6-month assessment for participants with coronary heart disease (n=453).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><figDesc><div><p xml:id="_D5sUSrf"><s xml:id="_g7mHnAt">45.9 to 48.0) 46.6 (45.6 to 47.7) Quality of life: physical component summary, adjusted mean (95% CI) .58</s><s xml:id="_VNEnzVz">0.3 (-0.8 to 1.4) b 49.5 (48.7 to 50.3) 49.2 (48.4 to 50.0) Quality of life: mental component summary, adjusted mean (95% CI) .42</s><s xml:id="_cSnvnZj">-0.3 (-1.1 to 0.5) b 5.0 (4.4 to 5.6) 5.3 (4.8 to 5.9) Depression score (PHQ-9 j ), adjusted mean (Missed medication on at least one of the last 30 days, n (%) a Number of participants with data available for the primary outcome.</s><s xml:id="_r3EJvVB">b Adjusted mean difference.</s><s xml:id="_qt65YZh">c Relative risk.</s><s xml:id="_mHZWV45">d LDL: low-density lipoprotein.</s><s xml:id="_FJV5pGm">e MET: metabolic equivalent of task.</s><s xml:id="_EzjnzPt">j PHQ-9: Patient Health Questionnaire-9.</s><s xml:id="_ztKXFq7">k n=203.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_SFguS4U"><s xml:id="_6fZAn79">Baseline characteristics by treatment group (n=902).</s></p></div></figDesc><table><row><cell>Control (n=448)</cell><cell>Intervention (n=454)</cell><cell>Total</cell></row><row><cell>61.9 (12.0)</cell><cell>61.0 (11.1)</cell><cell>61.5 (11.6)</cell></row></table><note xml:id="_xReb4Wd"><p>a CHD: coronary heart disease. b n=258. c n=262. d n=520. e CABG: coronary artery bypass graft. f PCI: percutaneous coronary intervention. g n=446. h n=450. i n=896. j n=449. k n=897. l n=447. m n=901. n GP: general practice. o n=445. p n=895. q MET: metabolic equivalent of task. r SBP: systolic blood pressure. s DBP: diastolic blood pressure.</p><p>t LDL: low-density lipoprotein.</p><p>u HDL: high-density lipoprotein.</p><p>v HbA 1c : glycated hemoglobin; performed for participants with diabetes only. w ACE: angiotensin-converting enzyme.</p><p>x DPP: dipeptidyl peptidase. y SGLT: sodium-glucose cotransporter.</p><p><s xml:id="_DMD6PFH">z GLP: glucagon-like peptide.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_9TzrSCm"><s xml:id="_bzkrVGw">Primary and secondary outcomes at the 6-month assessment.</s><s xml:id="_5tVDGgy">Analyses for each outcome were adjusted for the baseline measure of that specific outcome (n=807).</s></p></div></figDesc><table><row><cell>Control (n=404)</cell><cell>Intervention (n=403)</cell><cell>Adjusted mean difference a or</cell><cell>P value</cell></row><row><cell></cell><cell></cell><cell>relative risk b (95% CI)</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3 .</head><label>3</label><figDesc><div><p xml:id="_Cmy9q5r"><s xml:id="_TUjC8fX">Baseline characteristics of participants with type 2 diabetes by treatment group (n=642).</s></p></div></figDesc><table><row><cell>Control (n=323)</cell><cell>Intervention (n=319)</cell><cell>Total</cell></row><row><cell>60.7 (11.8)</cell><cell>59.7 (11.0)</cell><cell>60.2 (11.4)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 4 .</head><label>4</label><figDesc><div><p xml:id="_JtAZPEA"><s xml:id="_kYBPACF">Primary and secondary outcomes at the 6-month assessment for type 2 diabetes (n=569).</s></p></div></figDesc><table><row><cell>Control (n=292) a</cell><cell>Intervention (n=277) a</cell><cell>Adjusted mean difference b or</cell><cell>P value</cell></row><row><cell></cell><cell></cell><cell>relative risk c (95% CI)</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 5 .</head><label>5</label><figDesc><div><p xml:id="_pBRRFxY"><s xml:id="_4NjSBPk">Baseline characteristics of participants with coronary heart disease (CHD) by treatment group (n=506).</s></p></div></figDesc><table><row><cell>Control (n=250)</cell><cell>Intervention (n=256)</cell><cell>Total</cell></row><row><cell>64.8 (11.1)</cell><cell>63.2 (10.4)</cell><cell>64.0 (10.8)</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_4r7AaUy"><s xml:id="_qN3G4wz">J Med Internet Res 2023 | vol. 25 | e38275 | p. 2 https://www.jmir.org/2023/1/e38275</s><s xml:id="_gVv3yAg">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_Y5b4ERQ"><s xml:id="_AbJr2vu">J Med Internet Res 2023 | vol. 25 | e38275 | p. 3 https://www.jmir.org/2023/1/e38275</s><s xml:id="_7RTSnDW">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_DvCrVF4"><s xml:id="_8FAwbj5">J Med Internet Res 2023 | vol. 25 | e38275 | p. 4 https://www.jmir.org/2023/1/e38275</s><s xml:id="_U22rNbj">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_3"><p xml:id="_dnHzjNd"><s xml:id="_774qNUq">J Med Internet Res 2023 | vol. 25 | e38275 | p. 5 https://www.jmir.org/2023/1/e38275(page</s><s xml:id="_Drk5zTe">number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_4"><p xml:id="_v8TxYRd"><s xml:id="_fYMAUT9">J Med Internet Res 2023 | vol. 25 | e38275 | p. 6 https://www.jmir.org/2023/1/e38275</s><s xml:id="_RuTNWJq">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_5"><p xml:id="_6bTEGUf"><s xml:id="_NpM6SJR">J Med Internet Res 2023 | vol. 25 | e38275 | p. 7 https://www.jmir.org/2023/1/e38275</s><s xml:id="_ExJJS4s">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_6"><p xml:id="_efxnCWr"><s xml:id="_QC2vrRg">J Med Internet Res 2023 | vol. 25 | e38275 | p. 8 https://www.jmir.org/2023/1/e38275</s><s xml:id="_EVEuHZY">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_7"><p xml:id="_NRaCktt"><s xml:id="_CZE277X">J Med Internet Res 2023 | vol. 25 | e38275 | p. 9 https://www.jmir.org/2023/1/e38275</s><s xml:id="_6S4mn59">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_8"><p xml:id="_MuQUNGn"><s xml:id="_utgDFA6">J Med Internet Res 2023 | vol. 25 | e38275 | p. 10 https://www.jmir.org/2023/1/e38275</s><s xml:id="_QjBXMwq">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_9"><p xml:id="_3F5nChR"><s xml:id="_YeurWjn">J Med Internet Res 2023 | vol. 25 | e38275 | p. 11 https://www.jmir.org/2023/1/e38275</s><s xml:id="_c9YHDWD">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_10"><p xml:id="_j6XwkAK"><s xml:id="_dfnTNs7">J Med Internet Res 2023 | vol. 25 | e38275 | p. 12 https://www.jmir.org/2023/1/e38275</s><s xml:id="_y8heeCj">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_11"><p xml:id="_dkRQDDV"><s xml:id="_rJrwMfx">J Med Internet Res 2023 | vol. 25 | e38275 | p. 13 https://www.jmir.org/2023/1/e38275</s><s xml:id="_NyKudDF">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_12"><p xml:id="_fQnyjJd"><s xml:id="_k3QtueB">J Med Internet Res 2023 | vol. 25 | e38275 | p. 14 https://www.jmir.org/2023/1/e38275</s><s xml:id="_9SM5Njw">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_13"><p xml:id="_G6wCyeZ"><s xml:id="_UQKewvM">J Med Internet Res 2023 | vol. 25 | e38275 | p. 15 https://www.jmir.org/2023/1/e38275</s><s xml:id="_WvT9qv9">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_14"><p xml:id="_5g8NwNG"><s xml:id="_T7jGq9W">J Med Internet Res 2023 | vol. 25 | e38275 | p. 17 https://www.jmir.org/2023/1/e38275</s><s xml:id="_FnHrTB5">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_15"><p xml:id="_KwRGMA4"><s xml:id="_3xdgqxg">J Med Internet Res 2023 | vol. 25 | e38275 | p. 18 https://www.jmir.org/2023/1/e38275</s><s xml:id="_v77HdVT">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_16"><p xml:id="_wZkA9HK"><s xml:id="_U36tSr9">J Med Internet Res 2023 | vol. 25 | e38275 | p. 19 https://www.jmir.org/2023/1/e38275</s><s xml:id="_3JVtCK4">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_17"><p xml:id="_CqBszrB"><s xml:id="_ugeSgwC">J Med Internet Res 2023 | vol. 25 | e38275 | p. 20 https://www.jmir.org/2023/1/e38275</s><s xml:id="_QueH5va">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_18"><p xml:id="_UzXRq3r"><s xml:id="_ERPxWpa">J Med Internet Res 2023 | vol. 25 | e38275 | p. 21 https://www.jmir.org/2023/1/e38275</s><s xml:id="_NCWxgTq">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_19"><p xml:id="_rYpvTtU"><s xml:id="_BC6DGj3">J Med Internet Res 2023 | vol. 25 | e38275 | p. 22 https://www.jmir.org/2023/1/e38275</s><s xml:id="_R2AFxjd">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_20"><p xml:id="_39czFSe"><s xml:id="_x9cmdqc">J Med Internet Res 2023 | vol. 25 | e38275 | p. 23 https://www.jmir.org/2023/1/e38275</s><s xml:id="_YSVBqAW">(page number not for citation purposes)</s></p></note>
		</body>
		<back>


			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jqTY5Ry">Acknowledgments</head></div>
			</div>


			<div type="funding">
<div xml:id="_dJYpD5A"><p xml:id="_PGvjVc2"><s xml:id="_PMA5yFr">Funding was provided by the <rs type="funder">New South Wales Translational Research</rs> Grants Scheme.</s><s xml:id="_sgVBBeF">JR was funded by a <rs type="funder">National Health and Medical Research Council (NHMRC) of</rs> <rs type="grantName">Australia Career Development Fellowship</rs> (<rs type="grantNumber">APP1143538</rs>).</s><s xml:id="_mqDZh2h">CKC was funded by a <rs type="grantName">Career Development Fellowship</rs> cofunded by the <rs type="funder">NHMRC</rs> and the <rs type="funder">National Heart Foundation</rs> (<rs type="grantNumber">APP1105447</rs>).</s><s xml:id="_CeBQD8Z">RH was funded by a <rs type="funder">Westmead Hospital Jerry Koutts Scholarship</rs>.</s><s xml:id="_RDcw8fe">The funders were not involved in the design of the study; collection, analysis, and interpretation of the data; and writing of the report and did not impose any restrictions regarding its publication.</s><s xml:id="_sbzfjRp">This study was supported by the <rs type="funder">Western Sydney Local Health District</rs>, the <rs type="funder">National Heart Foundation</rs>, the <rs type="funder">New South Wales Agency for Clinical Innovation, Diabetes NSW &amp; ACT (New South Wales &amp; Australian Capital Territory)</rs>, the <rs type="funder">University of Sydney</rs>, and the <rs type="funder">George Institute.Diabetes NSW &amp; ACT</rs> supported and promoted the study and participated in message development.</s></p><p xml:id="_xqNMPKD"><s xml:id="_XRZ5zR9">The contributors associated with The SupportMe Investigators are as follows: <rs type="person">Nicola Barrie</rs>, <rs type="person">David Burgess</rs>, <rs type="person">Bridie Carr</rs>, <rs type="person">Lily Chen</rs>, <rs type="person">Michael Crampton</rs>, <rs type="person">Cate Ferry</rs>, <rs type="person">Peter Hay</rs>, <rs type="person">Alison Hayes</rs>, <rs type="person">Sheikh Mohammed Shariful Islam</rs>, <rs type="person">Simon Raadsma</rs>, <rs type="person">Chris Rissel</rs>, <rs type="person">Gillian Rosic</rs>, <rs type="person">N Wah Cheung</rs>, <rs type="person">Jin-Gun Cho</rs>, <rs type="person">Clara K Chow</rs>, <rs type="person">Sonia Faruquie</rs>, <rs type="person">Rabbia Haider</rs>, <rs type="person">Tien-Ming Hng</rs>, <rs type="person">Daniel McIntyre</rs>, <rs type="person">Julie Redfern</rs>, <rs type="person">Shelley She</rs>, <rs type="person">Aravinda Thiagalingam</rs>, and <rs type="person">Amy Von Huben</rs>.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_cun8Rrs">
					<idno type="grant-number">APP1143538</idno>
					<orgName type="grant-name">Australia Career Development Fellowship</orgName>
				</org>
				<org type="funding" xml:id="_HBANVAw">
					<orgName type="grant-name">Career Development Fellowship</orgName>
				</org>
				<org type="funding" xml:id="_mmcDSmZ">
					<idno type="grant-number">APP1105447</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_eqcJkD9">Conflicts of Interest</head><p xml:id="_ANv4maQ"><s xml:id="_gWkZDU6">JR is part owner of Textcare IP and holds a National Health and Medical Research Council (NHMRC) Investigator Grant Leadership Level 2.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_M82uKYW">Multimedia Appendix 1</head><p xml:id="_97vjrA6"><s xml:id="_xvgaNCR">Number of SMS text messages available for each health condition by topic addressed, questions used as a guide to facilitate focus group discussions, and example quotations illustrating the 5 major themes identified as enablers in SupportMe focus groups, respectively.</s><s xml:id="_JjKZzpH">©Ngai Wah Cheung, Julie Redfern, Aravinda Thiagalingam, Tien-Ming Hng, Simone Marschner, Rabbia Haider, Sonia Faruquie, Amy Von Huben, Shelley She, Daniel McIntyre, Jin-Gun Cho, Clara K Chow, The SupportMe Investigators.</s><s xml:id="_8ZYhxuc">Originally published in the Journal of Medical Internet Research (<ref type="url" target="https://www.jmir.org">https://www.jmir.org</ref>),</s><s xml:id="_dGewPWE"><ref type="bibr">16.06.2023</ref>.</s><s xml:id="_8qJynu6">This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ref type="url" target="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ref>),</s><s xml:id="_WJArcNC">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited.</s><s xml:id="_AQc4QcQ">The complete bibliographic information, a link to the original publication on <ref type="url" target="https://www.jmir.org/">https://www.jmir.org/</ref>,</s><s xml:id="_82C8U3V">as well as this copyright and license information must be included.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_YhFcP8P">Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015</title>
		<author>
			<persName><surname>Gbd</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(16)31012-1</idno>
		<idno>Medline: 27733281</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zmHrk36">Lancet</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="issue">10053</biblScope>
			<biblScope unit="page" from="1459" to="1544" />
			<date type="published" when="2015">2015. 2016 Oct 08</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016 Oct 08;388(10053):1459-1544 [FREE Full text] [doi: 10.1016/S0140-6736(16)31012-1] [Medline: 27733281]</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_bQ3ft6y">The impact of disease on family members: a critical aspect of medical care</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Golics</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Basra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Finlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Salek</surname></persName>
		</author>
		<idno type="DOI">10.1177/0141076812472616</idno>
		<idno>Medline: 23759884</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qBsMUUM">J R Soc Med</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="399" to="407" />
			<date type="published" when="2013-10">2013 Oct</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Golics CJ, Basra MK, Finlay AY, Salek S. The impact of disease on family members: a critical aspect of medical care. J R Soc Med 2013 Oct;106(10):399-407 [FREE Full text] [doi: 10.1177/0141076812472616] [Medline: 23759884]</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_KWybHWt">Economic costs of chronic disease through lost productive life years (PLYs) among Australians aged 45-64 years from 2015 to 2030: results from a microsimulation model</title>
		<author>
			<persName><forename type="first">D</forename><surname>Schofield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Shrestha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Cunich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tanton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Veerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Kelly</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2016-011151</idno>
		<idno>Medline: 27660315</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hDqndrV">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">11151</biblScope>
			<date type="published" when="2016-09-22">2016 Sep 22</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Schofield D, Shrestha RN, Cunich MM, Tanton R, Veerman L, Kelly SJ, et al. Economic costs of chronic disease through lost productive life years (PLYs) among Australians aged 45-64 years from 2015 to 2030: results from a microsimulation model. BMJ Open 2016 Sep 22;6(9):e011151 [FREE Full text] [doi: 10.1136/bmjopen-2016-011151] [Medline: 27660315]</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_ZTpwkN6">Text messaging-based interventions for smoking cessation: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Scott-Sheldon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lantini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Jennings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thind</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Rosen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Salmoirago-Blotcher</surname></persName>
		</author>
		<idno type="DOI">10.2196/mhealth.5436</idno>
		<idno>Medline: 27207211</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vMasa5J">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Scott-Sheldon LA, Lantini R, Jennings EG, Thind H, Rosen RK, Salmoirago-Blotcher E, et al. Text messaging-based interventions for smoking cessation: a systematic review and meta-analysis. JMIR Mhealth Uhealth 2016;4(2):e49 [FREE Full text] [doi: 10.2196/mhealth.5436] [Medline: 27207211]</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_q4E5Yeq">Mobile phone-based interventions for smoking cessation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mcrobbie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gu</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd006611.pub4</idno>
		<idno>Medline: 27060875</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7gQxyJh">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">6611</biblScope>
			<date type="published" when="2016-04-10">2016 Apr 10</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev 2016 Apr 10;4(4):CD006611 [FREE Full text] [doi: 10.1002/14651858.CD006611.pub4] [Medline: 27060875]</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_XxRCbZP">A systematic review with meta-analyses of text message-delivered behaviour change interventions for weight loss and weight loss maintenance</title>
		<author>
			<persName><forename type="first">R</forename><surname>Skinner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gonet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Currie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hoddinott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">U</forename><surname>Dombrowski</surname></persName>
		</author>
		<idno type="DOI">10.1111/obr.12999</idno>
		<idno>Medline: 32043809</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_449GRzm">Obes Rev</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">12999</biblScope>
			<date type="published" when="2020-06">2020 Jun</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Skinner R, Gonet V, Currie S, Hoddinott P, Dombrowski SU. A systematic review with meta-analyses of text message-delivered behaviour change interventions for weight loss and weight loss maintenance. Obes Rev 2020 Jun;21(6):e12999 [doi: 10.1111/obr.12999] [Medline: 32043809]</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_GcYRYfs">Text message interventions for physical activity: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Duque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Huffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Healy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Celano</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2019.08.014</idno>
		<idno>Medline: 31759805</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rQY7u2j">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="142" to="151" />
			<date type="published" when="2020-01">2020 Jan</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Smith DM, Duque L, Huffman JC, Healy BC, Celano CM. Text message interventions for physical activity: a systematic review and meta-analysis. Am J Prev Med 2020 Jan;58(1):142-151 [FREE Full text] [doi: 10.1016/j.amepre.2019.08.014] [Medline: 31759805]</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_fhBK5un">Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kurup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Laba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Santo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodgers</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2015.7667</idno>
		<idno>Medline: 26831740</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kWdtvHK">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="340" to="349" />
			<date type="published" when="2016-03">2016 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Thakkar J, Kurup R, Laba T, Santo K, Thiagalingam A, Rodgers A, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med 2016 Mar;176(3):340-349 [doi: 10.1001/jamainternmed.2015.7667] [Medline: 26831740]</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_WbyNgcY">Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Hillis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Santo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Hackett</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2015.10945</idno>
		<idno>Medline: 26393848</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ushevde">JAMA</title>
		<imprint>
			<biblScope unit="volume">314</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1255" to="1263" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA 2015;314(12):1255-1263 [doi: 10.1001/jama.2015.10945] [Medline: 26393848]</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_B8yKpuE">Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events</title>
		<author>
			<persName><forename type="first">E</forename><surname>Burn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nghiem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jan</forename><forename type="middle">S</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1136/heartjnl-2016-310195</idno>
		<idno>Medline: 28235776</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jwBQWk9">Heart</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="893" to="894" />
			<date type="published" when="2017-06">2017 Jun</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Burn E, Nghiem S, Jan S, Redfern J, Rodgers A, Thiagalingam A, et al. Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events. Heart 2017 Jun;103(12):893-894 [FREE Full text] [doi: 10.1136/heartjnl-2016-310195] [Medline: 28235776]</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_73T5y9X">Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program</title>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Santo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Coorey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hackett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0163929</idno>
		<idno>Medline: 27741244</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_b3DmRUC">PLoS One</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">163929</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Redfern J, Santo K, Coorey G, Thakkar J, Hackett M, Thiagalingam A, et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLoS One 2016;11(10):e0163929 [FREE Full text] [doi: 10.1371/journal.pone.0163929] [Medline: 27741244]</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_BCS7uDB">Effect of lifestyle focused text messaging on risk factor modification in patients with diabetes and coronary heart disease: a sub-analysis of the TEXT ME study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Haider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hyun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2019.04.030</idno>
		<idno>Medline: 31063856</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ngDhKYK">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="184" to="190" />
			<date type="published" when="2019-07">2019 Jul</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haider R, Hyun K, Cheung NW, Redfern J, Thiagalingam A, Chow CK. Effect of lifestyle focused text messaging on risk factor modification in patients with diabetes and coronary heart disease: a sub-analysis of the TEXT ME study. Diabetes Res Clin Pract 2019 Jul;153:184-190 [doi: 10.1016/j.diabres.2019.04.030] [Medline: 31063856]</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_7bjgQh9">Mobile phone text messaging in improving glycaemic control for patients with type 2 diabetes mellitus: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Haider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sudini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Cheung</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2019.02.022</idno>
		<idno>Medline: 30822496</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ga6rEHa">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page" from="27" to="37" />
			<date type="published" when="2019-04">2019 Apr</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haider R, Sudini L, Chow CK, Cheung NW. Mobile phone text messaging in improving glycaemic control for patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract 2019 Apr;150:27-37 [doi: 10.1016/j.diabres.2019.02.022] [Medline: 30822496]</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_TGmGMh5">Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Maddison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shepherd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mcnamara</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.k1959</idno>
		<idno>Medline: 29773539</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YdZm8hS">BMJ</title>
		<imprint>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="page">1959</biblScope>
			<date type="published" when="2018-05-17">2018 May 17</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Dobson R, Whittaker R, Jiang Y, Maddison R, Shepherd M, McNamara C, et al. Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial. BMJ 2018 May 17;361:k1959 [FREE Full text] [doi: 10.1136/bmj.k1959] [Medline: 29773539]</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_QHfy8tA">Effects of a tailored text messaging intervention among diverse adults with type 2 diabetes: evidence from the 15-month REACH randomized controlled trial</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Greevy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Spieker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Wallston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Elasy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kripalani</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc20-0961</idno>
		<idno>Medline: 33154039</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KUZJDDG">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="26" to="34" />
			<date type="published" when="2021-01">2021 Jan</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Nelson LA, Greevy RA, Spieker A, Wallston KA, Elasy TA, Kripalani S, et al. Effects of a tailored text messaging intervention among diverse adults with type 2 diabetes: evidence from the 15-month REACH randomized controlled trial. Diabetes Care 2021 Jan;44(1):26-34 [FREE Full text] [doi: 10.2337/dc20-0961] [Medline: 33154039]</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_FFdAfx4">Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">X</forename><surname>Huo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Krumholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Bai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Spatz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Horak</surname></persName>
		</author>
		<idno type="DOI">10.1161/circoutcomes.119.005805</idno>
		<idno>Medline: 31474119</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jdhTk67">Circ Cardiovasc Qual Outcomes</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">5805</biblScope>
			<date type="published" when="2019-09">2019 Sep</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Huo X, Krumholz HM, Bai X, Spatz ES, Ding Q, Horak P, et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circ Cardiovasc Qual Outcomes 2019 Sep;12(9):e005805 [doi: 10.1161/CIRCOUTCOMES.119.005805] [Medline: 31474119]</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_k3wfQ4V">National Diabetes Services Scheme</title>
		<idno type="DOI">10.3998/mpub.11614217.cmp.19</idno>
		<ptr target="https://map.ndss.com.au" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_a6nGMhn">Australian diabetes map</title>
		<imprint>
			<date type="published" when="2022-03-13">2022-03-13</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Australian diabetes map. National Diabetes Services Scheme. URL: https://map.ndss.com.au, [accessed 2022-03-13]</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_h5MytBQ">Model for integrated care for chronic disease in the Australian context: western Sydney integrated care program</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Crampton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Nesire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Western</forename><surname>Sydney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Integrated</forename><surname>Care</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Program</forename><surname>Investigators</surname></persName>
		</author>
		<idno type="DOI">10.1071/ah18152</idno>
		<idno>Medline: 30862349</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3WKNJTY">Aust Health Rev</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="565" to="571" />
			<date type="published" when="2019-10">2019 Oct</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cheung NW, Crampton M, Nesire V, Hng T, Chow CK, Western Sydney Integrated Care Program Investigators. Model for integrated care for chronic disease in the Australian context: western Sydney integrated care program. Aust Health Rev 2019 Oct;43(5):565-571 [doi: 10.1071/AH18152] [Medline: 30862349]</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_bKGdKtv">Text messaging support for patients with diabetes or coronary artery disease (SupportMe): protocol for a pragmatic randomised controlled trial</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Haider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Supportme</forename><surname>Investigators</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2018-025923</idno>
		<idno>Medline: 31221870</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZE6mAap">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">25923</biblScope>
			<date type="published" when="2019-06-19">2019 Jun 19</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Cheung NW, Redfern J, Thiagalingam A, Hng T, Islam SM, Haider R, SupportMe investigators. Text messaging support for patients with diabetes or coronary artery disease (SupportMe): protocol for a pragmatic randomised controlled trial. BMJ Open 2019 Jun 19;9(6):e025923 [FREE Full text] [doi: 10.1136/bmjopen-2018-025923] [Medline: 31221870]</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_MV4dpVH">Design considerations in development of a mobile health intervention program: the TEXT ME and TEXTMEDS experience</title>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Barry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Mcewan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodgers</surname></persName>
		</author>
		<idno type="DOI">10.2196/mhealth.5996</idno>
		<idno>Medline: 27847350</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9pKMY2k">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">e127</biblScope>
			<date type="published" when="2016-11-15">2016 Nov 15</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Thakkar J, Barry T, Thiagalingam A, Redfern J, McEwan AL, Rodgers A, et al. Design considerations in development of a mobile health intervention program: the TEXT ME and TEXTMEDS experience. JMIR Mhealth Uhealth 2016 Nov 15;4(4):e127 [FREE Full text] [doi: 10.2196/mhealth.5996] [Medline: 27847350]</note>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<idno type="DOI">10.1097/01.hjr.0000368194.32356.5f</idno>
		<ptr target="https://strokefoundation.org.au/what-we-do/prevention-programs/position-and-submissions/alliances/nvdpa-alliance" />
		<title level="m" xml:id="_S4bqhAf">Guidelines for the management of absolute cardiovascular disease risk</title>
		<imprint>
			<date type="published" when="2023-03-28">2023-03-28</date>
		</imprint>
		<respStmt>
			<orgName>National Vascular Disease Prevention Alliance</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Guidelines for the management of absolute cardiovascular disease risk. National Vascular Disease Prevention Alliance. URL: https://strokefoundation.org.au/what-we-do/prevention-programs/position-and-submissions/alliances/nvdpa-alliance [accessed 2023-03-28]</note>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<idno type="DOI">10.1007/s10389-006-0024-x</idno>
		<ptr target="https://www.who.int/docs/default-source/ncds/ncd-surveillance/gpaq-analysis-guide.pdf?sfvrsn=1e83d571" />
		<title level="m" xml:id="_P39PuGk">Global physical activity questionnaire (GPAQ): analysis guide</title>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="2012">2012. 2023-03-28</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Global physical activity questionnaire (GPAQ): analysis guide. World Health Organization. 2012. URL: https://www. who.int/docs/default-source/ncds/ncd-surveillance/gpaq-analysis-guide.pdf?sfvrsn=1e83d571_2 [accessed 2023-03-28]</note>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<idno type="DOI">10.1007/978-1-4615-0071-1_3</idno>
		<ptr target="http://www.who.int/ncds/surveillance/steps/instrument/en/" />
		<title level="m" xml:id="_xK8fkRw">STEPwise approach to NCD risk factor surveillance (STEPS)</title>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="2021-08-11">2021-08-11</date>
		</imprint>
	</monogr>
	<note type="raw_reference">STEPwise approach to NCD risk factor surveillance (STEPS). World Health Organization. URL: http://www.who.int/ncds/ surveillance/steps/instrument/en/ [accessed 2021-08-11]</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_vA8GSnZ">A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ware</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kosinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Keller</surname></persName>
		</author>
		<idno type="DOI">10.1097/00005650-199603000-00003</idno>
		<idno>Medline: 8628042</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Fz6HpXC">Med Care</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="220" to="233" />
			<date type="published" when="1996-03">1996 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996 Mar;34(3):220-233 [doi: 10.1097/00005650-199603000-00003] [Medline: 8628042]</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_ZbYVUSt">Performance of the PHQ-9 as a screening tool for depression after stroke</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Brizendine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Plue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Tu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hendrie</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.str.0000155688.18207.33</idno>
		<idno>Medline: 15677576</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Q6xF4CY">Stroke</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="635" to="638" />
			<date type="published" when="2005-03">2005 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Williams LS, Brizendine EJ, Plue L, Bakas T, Tu W, Hendrie H, et al. Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke 2005 Mar;36(3):635-638 [doi: 10.1161/01.STR.0000155688.18207.33] [Medline: 15677576]</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_4ug2Pwa">Temporal HbA1c patterns amongst patients with type 2 diabetes referred for specialist care: data from the S4S-DINGO-Diabetes Informatics Group</title>
		<author>
			<persName><forename type="first">T</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Hoffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cukier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Darnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Greenfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Harrison</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2016.04.006</idno>
		<idno>Medline: 27321331</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7jMpE7f">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="159" to="164" />
			<date type="published" when="2016-06">2016 Jun</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lam T, Hoffman DM, Cukier K, Darnell D, Greenfield JR, Harrison N, et al. Temporal HbA1c patterns amongst patients with type 2 diabetes referred for specialist care: data from the S4S-DINGO-Diabetes Informatics Group. Diabetes Res Clin Pract 2016 Jun;116:159-164 [doi: 10.1016/j.diabres.2016.04.006] [Medline: 27321331]</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_yPDxMcJ">Effectiveness and acceptability of a text message intervention (DTEXT) on HbA1c and self-management for people with type 2 diabetes. A randomized controlled trial</title>
		<author>
			<persName><forename type="first">K</forename><surname>Waller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Furber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bauman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Allman-Farinelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van Den Dolder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hayes</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pec.2020.11.038</idno>
		<idno>Medline: 33334634</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3DCtkrZ">Patient Educ Couns</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1736" to="1744" />
			<date type="published" when="2021-07">2021 Jul</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Waller K, Furber S, Bauman A, Allman-Farinelli M, van den Dolder P, Hayes A, et al. Effectiveness and acceptability of a text message intervention (DTEXT) on HbA1c and self-management for people with type 2 diabetes. A randomized controlled trial. Patient Educ Couns 2021 Jul;104(7):1736-1744 [doi: 10.1016/j.pec.2020.11.038] [Medline: 33334634]</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_ZhCH6Q4">Guideline for the diagnosis and management of hypertension in adults -2016</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Gabb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Mangoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cowley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Dowden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Golledge</surname></persName>
		</author>
		<idno type="DOI">10.5694/mja16.00526</idno>
		<idno>Medline: 27456450</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8VNy87b">Med J Aust</title>
		<imprint>
			<biblScope unit="volume">205</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="85" to="89" />
			<date type="published" when="2016-07-18">2016 Jul 18</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gabb GM, Mangoni AA, Anderson CS, Cowley D, Dowden JS, Golledge J, et al. Guideline for the diagnosis and management of hypertension in adults -2016. Med J Aust 2016 Jul 18;205(2):85-89 [doi: 10.5694/mja16.00526] [Medline: 27456450]</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_d2Drg7y">Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Faruque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wiebe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ehteshami-Afshar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dianati-Maleki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Hemmelgarn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alberta</forename><surname>Kidney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Disease</forename><surname>Network</surname></persName>
		</author>
		<idno type="DOI">10.1503/cmaj.150885</idno>
		<idno>Medline: 27799615</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_K9REx94">CMAJ</title>
		<imprint>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="341" to="E364" />
			<date type="published" when="2017-03-06">2017 Mar 06</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Faruque LI, Wiebe N, Ehteshami-Afshar A, Liu Y, Dianati-Maleki N, Hemmelgarn BR, Alberta Kidney Disease Network. Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. CMAJ 2017 Mar 06;189(9):E341-E364 [FREE Full text] [doi: 10.1503/cmaj.150885] [Medline: 27799615]</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_YgsEkyB">Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Klimis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Hillis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Brieger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">*</forename><surname>Textmeds Investigators</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.121.056161</idno>
		<idno>Medline: 35533220</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tP3EGjD">Circulation</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="1443" to="1455" />
			<date type="published" when="2022-05-10">2022 May 10</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK, Klimis H, Thiagalingam A, Redfern J, Hillis GS, Brieger D, TEXTMEDS Investigators*. Text messages to improve medication adherence and secondary prevention after acute coronary syndrome: the TEXTMEDS randomized clinical trial. Circulation 2022 May 10;145(19):1443-1455 [doi: 10.1161/CIRCULATIONAHA.121.056161] [Medline: 35533220]</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_eGAscMg">Patients with lower activation associated with higher costs; delivery systems should know their patients&apos; &apos;scores</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Hibbard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Greene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Overton</surname></persName>
		</author>
		<idno type="DOI">10.1377/hlthaff.2012.1064</idno>
		<idno>Medline: 23381513</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_H94qQug">Health Aff (Millwood)</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="216" to="222" />
			<date type="published" when="2013-02">2013 Feb</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hibbard JH, Greene J, Overton V. Patients with lower activation associated with higher costs; delivery systems should know their patients&apos; &apos;scores&apos;. Health Aff (Millwood) 2013 Feb;32(2):216-222 [doi: 10.1377/hlthaff.2012.1064] [Medline: 23381513]</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_3Fvxtz9">Development of a set of mobile phone text messages designed for prevention of recurrent cardiovascular events</title>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jan</forename><forename type="middle">S</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hackett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Mooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
		<idno type="DOI">10.1177/2047487312449416</idno>
		<idno>Medline: 22605787</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gV97Zrg">Eur J Prev Cardiol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="492" to="499" />
			<date type="published" when="2014-04">2014 Apr</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Redfern J, Thiagalingam A, Jan S, Whittaker R, Hackett ML, Mooney J, et al. Development of a set of mobile phone text messages designed for prevention of recurrent cardiovascular events. Eur J Prev Cardiol 2014 Apr;21(4):492-499 [doi: 10.1177/2047487312449416] [Medline: 22605787]</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_BzSv9jP">Text messages promoting healthy lifestyle and linked with activity monitors stimulate an immediate increase in physical activity among women after gestational diabetes</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Barry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mercorelli</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2022.109991</idno>
		<idno>Medline: 35835256</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HAhvx44">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="page">109991</biblScope>
			<date type="published" when="2022-08">2022 Aug</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cheung NW, Thiagalingam A, Smith BJ, Redfern J, Barry T, Mercorelli L, et al. Text messages promoting healthy lifestyle and linked with activity monitors stimulate an immediate increase in physical activity among women after gestational diabetes. Diabetes Res Clin Pract 2022 Aug;190:109991 [doi: 10.1016/j.diabres.2022.109991] [Medline: 35835256]</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_RyaYcH5">Targeted, structured text messaging to improve dietary and lifestyle behaviours for people on maintenance haemodialysis (KIDNEYTEXT): study protocol for a randomised controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Stevenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Craig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Howell</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2018-023545</idno>
		<idno>Medline: 31061013</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YR3Swga">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">23545</biblScope>
			<date type="published" when="2019-05-05">2019 May 05</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Stevenson J, Campbell KL, Brown M, Craig J, Howard K, Howell M, et al. Targeted, structured text messaging to improve dietary and lifestyle behaviours for people on maintenance haemodialysis (KIDNEYTEXT): study protocol for a randomised controlled trial. BMJ Open 2019 May 05;9(5):e023545 [FREE Full text] [doi: 10.1136/bmjopen-2018-023545] [Medline: 31061013]</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_wH8RKj4">A daily SMS reminder increases adherence to asthma treatment: a three-month follow-up study</title>
		<author>
			<persName><forename type="first">U</forename><surname>Strandbygaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Thomsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Backer</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.rmed.2009.10.003</idno>
		<idno>Medline: 19854632</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xaGV7vw">Respir Med</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="166" to="171" />
			<date type="published" when="2010-02">2010 Feb</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Strandbygaard U, Thomsen SF, Backer V. A daily SMS reminder increases adherence to asthma treatment: a three-month follow-up study. Respir Med 2010 Feb;104(2):166-171 [FREE Full text] [doi: 10.1016/j.rmed.2009.10.003] [Medline: 19854632]</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_txuVfvT">The effectiveness of self-management of hypertension in adults using mobile health: systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hesketh</surname></persName>
		</author>
		<idno type="DOI">10.2196/17776</idno>
		<idno>Medline: 32217503</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aaeRXf2">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">17776</biblScope>
			<date type="published" when="2020-03-27">2020 Mar 27</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Li R, Liang N, Bu F, Hesketh T. The effectiveness of self-management of hypertension in adults using mobile health: systematic review and meta-analysis. JMIR Mhealth Uhealth 2020 Mar 27;8(3):e17776 [FREE Full text] [doi: 10.2196/17776] [Medline: 32217503]</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_8h4afRb">Effectiveness of text messaging interventions for the management of depression: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Senanayake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Wickramasinghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Chatfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Edirippulige</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x19875852</idno>
		<idno>Medline: 31631764</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7Mt9Vg7">J Telemed Telecare</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="513" to="523" />
			<date type="published" when="2019-10">2019 Oct</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Senanayake B, Wickramasinghe SI, Chatfield MD, Hansen J, Edirippulige S, Smith AC. Effectiveness of text messaging interventions for the management of depression: a systematic review and meta-analysis. J Telemed Telecare 2019 Oct;25(9):513-523 [doi: 10.1177/1357633X19875852] [Medline: 31631764]</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
